This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_UNCERTAIN_SECONDARY_EXALLC for full statistics.
Secondary uncertain malignant neoplasm
C3_UNCERTAIN_SECONDARY
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
5134 |
6. Filter based on genotype QC (FinnGen only) |
5134 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF4
Similar endpoints
↥List of similar endpoints to
Secondary uncertain malignant neoplasm
based on the number of shared cases.
Similar with more cases:
- Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5134 | 2179 | 2955 |
| Unadjusted period prevalence (%) | 1.07 | 0.74 | 1.30 |
| Median age at first event (years) | 66.41 | 64.41 | 67.88 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4599
- Matched controls
- 45988
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
PJA10
NOMESCO Finland
Exploration of lymph nodes
51.2
323.0
571
127
H02AB02
ATC
dexamethasone; systemic
5.7
323.0
1110
2442
A04AA02
ATC
granisetron; systemic, transdermal
8.8
323.0
882
1213
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
898.0
323.0
410
5
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
71.0
323.0
736
123
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
27.6
323.0
683
289
M04AA01
ATC
allopurinol; systemic
4.7
323.0
1495
4270
L03AA02
ATC
filgrastim; parenteral
27.6
323.0
876
389
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
29.1
323.0
524
202
JN4BD
NOMESCO Finland
Extensive body CT
8.9
323.0
1685
2805
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
18.4
323.0
1129
800
A04AA01
ATC
ondansetron; systemic, rectal
8.1
323.0
924
1379
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
323.0
343
*
XW000
NOMESCO Finland
Bone marrow biopsy
12.5
323.0
897
871
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
42.3
323.0
583
157
A03FA01
ATC
metoclopramide; systemic, rectal
7.6
323.0
2358
5599
L03AA13
ATC
pegfilgrastim; parenteral
14.9
323.0
736
582
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
84.1
323.0
427
56
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
54.8
323.0
2219
769
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
91.4
323.0
947
130
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
32.5
323.0
966
373
C82.1
ICD-10 Finland
Follicular lymphoma grade II
226.4
323.0
540
27
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
406.3
307.7
306
8
8000/3-C80.9
ICD-O-3
Neoplasm, malignant of unknown primary site
+∞
302.5
287
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.8
273.4
626
810
N02AA05
ATC
oxycodone; systemic
3.9
272.2
1367
4495
JN6AD
NOMESCO Finland
CT of torso and neck
27.5
270.7
378
149
WW500
NOMESCO Finland
Blood transfusion
8.6
262.2
606
794
JN4AD
NOMESCO Finland
Body CT examination
5.3
250.4
860
1925
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
265.3
247.0
251
10
C80
ICD-10 Finland
Malignant neoplasm, without specification of site
424.5
244.3
243
6
Z51.5
ICD-10 Finland
Palliative care
5.7
239.4
753
1514
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
193.8
230.6
239
13
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
230.1
219
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.9
225.6
1958
9385
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
321.5
211.4
213
7
WF049
NOMESCO Finland
Radiotherapy of metastasis
8.6
209.9
482
616
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
61.8
209.7
246
42
1XC02
NOMESCO Finland
NA
36.3
205.4
267
78
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
29.2
202.7
278
101
8140/3-C80.9
ICD-O-3
Adenocarcinoma, NOS, of unknown primary site
+∞
200.5
191
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
32.7
199.7
266
86
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
76.4
198.8
226
31
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.4
197.9
653
1371
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
17.0
196.5
321
202
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
25.3
191.9
274
115
130
Kela drug reimbursment
Malignant tumour
4.1
186.9
818
2288
A49.9
ICD-10 Finland
Bacterial infection, unspecified
3.7
185.6
955
3073
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
10.6
184.4
374
381
C83.1
ICD-10 Finland
Mantle cell lymphoma
56.0
183.7
219
41
ZX120
NOMESCO Finland
Intravenous
4.0
177.8
807
2324
D70.82
ICD-10 Finland
Drug-induced neutropenia
15.0
177.6
305
217
9691/3-C77.9
ICD-O-3
Follicular lymphoma, grade 2 of lymph node, NOS
+∞
176.2
168
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.6
175.5
556
1105
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
446.6
174.0
173
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
170.2
171.9
180
11
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
14.4
167.2
292
216
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
60.1
166.4
196
34
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
7.0
163.9
431
670
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
114.3
162.3
176
16
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
11.2
157.6
310
296
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
49.7
157.0
191
40
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
156.4
951
3432
C83.00
ICD-10 Finland
Lymphocytic lymphoma
69.2
156.2
180
27
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
30.0
155.9
212
74
R50.9
ICD-10 Finland
Fever, unspecified
3.1
150.4
979
3693
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
22.2
149.6
222
105
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.8
147.3
394
625
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.0
143.7
496
1077
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.2
133.5
2368
15132
9663/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph node, NOS
+∞
132.9
127
*
C81.2
ICD-10 Finland
Mixed cellularity classical Hodgkin lymphoma
+∞
130.8
125
*
L03AA14
ATC
lipegfilgrastim; parenteral
10.8
128.9
257
251
H02AB06
ATC
prednisolone; systemic
2.1
128.8
2409
15655
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
11.7
124.3
238
214
C81.7
ICD-10 Finland
Other classical Hodgkin lymphoma
415.0
122.3
122
*
C80.0
ICD-10 Finland
Malignant neoplasm, primary site unknown, so stated
+∞
120.3
115
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
119.3
114
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
12.5
117.4
217
181
WF003
NOMESCO Finland
Adjuvant radiotherapy
5.7
114.6
352
663
8070/3-C80.9
ICD-O-3
Squamous cell carcinoma, NOS, of unknown primary site
+∞
113.0
108
*
XX3DW
NOMESCO Finland
Time consuming IT work
3.1
111.8
699
2517
JN4CD
NOMESCO Finland
Very extensive body CT
4.8
110.0
395
886
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
22.9
105.9
155
70
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
105.6
101
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.9
100.8
297
530
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
999.7
100.5
98
*
A02BC02
ATC
pantoprazole; systemic
2.0
99.6
3042
22920
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
13.4
96.3
172
133
J01MA12
ATC
levofloxacin; systemic
2.2
94.2
1131
5835
C80.99
ICD-10 Finland
Malignant tumor without specified localization or histology
62.0
93.2
109
18
XX9CD
NOMESCO Finland
Very extensive complementary CT
94.8
92.3
102
11
ZX112
NOMESCO Finland
Subcutaneous
6.6
91.5
248
396
8010/3-C80.9
ICD-O-3
Carcinoma, NOS, of unknown primary site
+∞
87.8
84
*
9663/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of multiple regions
+∞
87.8
84
*
WZC30
NOMESCO Finland
Teaching
2.5
87.0
762
3336
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
+∞
85.7
82
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
25.6
85.0
120
48
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
9.6
84.7
179
194
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
3.6
83.8
410
1215
20199
ICD-8 Finland
Hodgkin's disease
833.2
83.8
82
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
6.7
83.7
222
344
WF002
NOMESCO Finland
Radical radiotherapy
3.6
82.8
408
1216
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
125.1
80.2
86
7
WF004
NOMESCO Finland
Palliative radiotherapy
6.3
79.1
221
367
H02AB07
ATC
prednisone; oral
2.3
77.8
820
3932
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
76.6
1308
7717
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
59.8
75.0
88
15
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
9.0
73.9
161
184
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
7.0
73.6
189
280
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
83.5
73.2
82
10
9691/3-C77.8
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of multiple regions
+∞
73.1
70
*
9650/3-C77.0
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of head, face and neck
+∞
73.1
70
*
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
65.7
72.6
84
13
A04AD12
ATC
aprepitant; systemic
7.1
72.0
183
267
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
6.2
71.9
203
342
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.8
71.8
255
561
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
12.0
71.6
134
115
212
Kela drug reimbursment
Gout
5.1
71.1
236
483
9680/3-C80.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of unknown primary site
+∞
71.0
68
*
C22.9
ICD-10 Finland
Malignant neoplasm: Liver, unspecified
19.2
70.7
109
58
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
8.8
68.6
151
176
L01AA02
ATC
chlorambucil; oral
23.5
68.6
99
43
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.2
68.1
397
1337
B72
ICPC
Hodgkin Lymphoma
58.1
67.9
80
14
9698/3-C77.9
ICD-O-3
Follicular lymphoma, grade 3 of lymph node, NOS
+∞
66.8
64
*
9690/3-C77.9
ICD-O-3
Follicular lymphoma, NOS, of lymph node, NOS
+∞
66.8
64
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
3.3
66.8
362
1157
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.2
66.7
376
1236
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
9.6
66.5
139
148
J05AB11
ATC
valaciclovir; oral
2.3
64.6
654
3051
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
25.5
63.9
90
36
B01AB05
ATC
enoxaparin; parenteral
1.8
63.6
1460
9431
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.8
63.1
220
474
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.4
62.6
589
2643
ZX070
NOMESCO Finland
Intensity modified radiotherapy
5.5
62.1
193
366
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
45.4
61.8
76
17
9663/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of lymph nodes of head, face and neck
+∞
61.6
59
*
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
10.6
61.5
122
118
9591/3-C77.2
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intra-abdominal lymph nodes
+∞
59.5
57
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
9.7
57.9
120
126
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
9.1
57.7
124
139
9695/3-C77.9
ICD-O-3
Follicular lymphoma, grade 1 of lymph node, NOS
+∞
55.3
53
*
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
55.3
53
*
9591/3-C77.4
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of inguinal region or leg
+∞
54.3
52
*
L01CB01
ATC
etoposide; systemic
16.7
53.9
87
53
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
53.3
1026
6180
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
2.2
53.1
598
2911
C76.2
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Abdomen
53.2
52.8
63
12
2015X
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, NUD]
+∞
52.2
50
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.2
51.4
166
329
D70.89
ICD-10 Finland
Neutropenic splenomegaly
7.8
50.7
120
158
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
258.1
50.2
51
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
14.4
49.7
85
60
C80.9
ICD-10 Finland
Malignant neoplasm, primary site unspecified
493.0
49.5
49
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
5.0
49.0
163
334
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
48.9
1298
8617
9680/3-C77.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of head, face and neck
+∞
48.0
46
*
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
22.2
47.9
70
32
TGC00
NOMESCO Finland
Bronchial lavation
4.0
47.4
201
524
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
103.1
46.8
51
5
B01AB10
ATC
tinzaparin; parenteral
2.5
45.9
382
1595
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
17.8
45.8
72
41
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
9.3
45.4
96
105
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
36.7
45.4
58
16
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.7
45.3
209
586
A04AA55
ATC
palonosetron, combinations; systemic
4.5
45.0
166
380
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
44.9
416
1839
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
44.9
43
*
8246/3-C80.9
ICD-O-3
Neuroendocrine carcinoma, NOS, of unknown primary site
+∞
43.8
42
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
39.8
43.8
55
14
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
12.3
43.7
80
66
A07AA02
ATC
nystatin; oral
2.5
43.6
358
1480
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.9
43.4
125
217
4701
FHL
Neck lymph node removal
29.3
43.0
58
20
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
42.8
469
2245
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.3
42.8
435
2010
C83.33
ICD-10 Finland
Primary medical lymphoma with large B cells
216.9
41.9
43
*
WW409
NOMESCO Finland
Other aferesis
23.9
41.4
59
25
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
13.2
41.3
73
56
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
7.7
41.3
98
130
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
41.2
788
4681
2009X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma[LYMPHOMA MALIGNUM (NON-HODGKIN) NUD]
144.6
40.8
43
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.7
40.7
187
523
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
108.5
39.8
43
*
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
17.2
39.7
63
37
9698/3-C77.8
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of multiple regions
+∞
39.6
38
*
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
39.4
1026
6698
1AA09
NOMESCO Finland
NA
44.0
39.1
48
11
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
38.9
1305
9117
A79
ICPC
Malignancy NOS
5.6
38.8
116
211
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.6
38.0
176
496
JAH00
NOMESCO Finland
Laparotomy
3.4
37.1
187
564
A41.9
ICD-10 Finland
Sepsis, unspecified
2.9
36.9
239
860
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
7.9
36.7
85
109
9652/3-C77.9
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph node, NOS
+∞
36.5
35
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
27.5
35.9
49
18
C83.32
ICD-10 Finland
Centroblastic diffuse non-Hodgkin's lymphoma
127.7
35.7
38
*
ZX108
NOMESCO Finland
Inhalation
8.4
35.5
79
95
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
5.0
35.4
116
235
A06AH03
ATC
naloxegol; oral
5.8
35.4
102
178
C84.51
ICD-10 Finland
Other and unspecified T-cell lymphomas
59.1
35.2
41
7
WW402
NOMESCO Finland
Leucoferesis
29.7
35.1
47
16
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
3.7
35.1
157
430
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
4.8
34.7
118
249
8720/3-C80.9
ICD-O-3
Malignant melanoma, NOS, of unknown primary site
+∞
34.4
33
*
9659/3-C77.8
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of multiple regions
+∞
34.4
33
*
9659/3-C77.9
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph node, NOS
+∞
34.4
33
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.6
34.0
270
1094
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
176.3
33.8
35
*
C81
ICD-10 Finland
Hodgkin lymphoma
+∞
33.4
32
*
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
33.4
32
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.5
33.1
269
1106
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
9.7
32.7
67
70
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.8
31.9
214
786
FM1FN
NOMESCO Finland
Heart function isotope examination
11.7
31.8
59
51
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
2.7
31.6
225
857
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
10.1
31.5
63
63
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
13.2
31.4
55
42
9591/3-C77.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of intrathoracic lymph nodes
+∞
31.3
30
*
9591/3-C77.8
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of multiple regions
+∞
31.3
30
*
9591/3-C77.3
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of axilla or arm
+∞
31.3
30
*
L01BC06
ATC
capecitabine; oral
2.9
31.2
198
704
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
3.9
30.6
131
346
7856A
ICD-9 Finland
Symptoms involving cardiovascular system, Enlargement of lymph nodes
19.3
30.4
46
24
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.1
30.3
122
305
2000A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM FOLLICULARE]
+∞
30.2
29
*
I88.9
ICD-10 Finland
Nonspecific lymphadenitis, unspecified
11.6
30.0
56
49
C83.35
ICD-10 Finland
T-cell-rich B-cell lymphoma
156.0
29.7
31
*
JAH21
NOMESCO Finland
Staging laparoscopy
107.4
29.7
32
*
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
29.6
533
3081
YNB10
NOMESCO Finland
Collection of stem cells for transplant
20.2
29.5
44
22
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
3.2
29.3
162
525
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.9
28.6
457
2532
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
28.6
498
2844
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
48.9
28.4
34
7
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
4.4
28.2
105
244
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
28.2
1917
15346
9670/3-C77.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph node, NOS
+∞
28.1
27
*
9650/3-C77.1
ICD-O-3
Hodgkin lymphoma, NOS, of intrathoracic lymph nodes
+∞
28.1
27
*
2019X
ICD-9 Finland
Hodgkin's disease, unspecified
+∞
28.1
27
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
64.4
27.9
32
5
C82
ICD-10 Finland
Follicular lymphoma
283.1
27.8
28
*
C82.0
ICD-10 Finland
Follicular lymphoma grade I
145.9
27.6
29
*
J94.8
ICD-10 Finland
Other specified pleural conditions
4.0
27.6
114
293
HA1AA
NOMESCO Finland
X-ray mammography
2.2
27.5
288
1344
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
6.8
27.3
69
102
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
30.2
27.2
36
12
9650/3-C77.9
ICD-O-3
Hodgkin lymphoma, NOS, of lymph node, NOS
+∞
27.1
26
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
27.0
324
1606
JAH01
NOMESCO Finland
Laparoscopy
2.7
26.8
191
727
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
19.2
26.5
40
21
C84.59
ICD-10 Finland
Other and unspecified T-cell lymphomas
19.2
26.5
40
21
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
5.6
26.3
78
142
C03CA01
ATC
furosemide; systemic
1.4
26.1
1496
11544
9680/3-C77.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of intra-abdominal lymph nodes
+∞
26.1
25
*
9690/3-C77.8
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of multiple regions
+∞
26.1
25
*
9695/3-C77.8
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of multiple regions
+∞
26.1
25
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
2.8
25.7
173
637
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
4.3
25.6
97
230
20298
ICD-8 Finland
Other neoplasms of lymphoid tissue, Lymphomata alia
135.7
25.6
27
*
B02
ICPC
Lymph gland(s) enlarged/painful
8.2
25.5
57
70
R18
ICD-10 Finland
Ascites
3.6
25.0
115
324
9652/3-C77.8
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of multiple regions
+∞
25.0
24
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.0
25.0
149
507
TPX15
NOMESCO Finland
Removal of vascular injection port
8.4
25.0
55
66
C26.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the digestive system
12.3
25.0
45
37
Z31.6
ICD-10 Finland
General counselling and advice on procreation
9.2
24.9
52
57
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
17.1
24.8
39
23
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
7.5
24.8
59
80
JN4DD
NOMESCO Finland
Scout CT scan of torso
19.6
24.7
37
19
PJ2HT
NOMESCO Finland
Biopsy of deep lymphnode with ultrasound guidance
90.6
24.7
27
*
J05AB01
ATC
aciclovir; systemic
1.6
24.6
787
5342
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.2
24.5
271
1296
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
12.3
24.5
44
36
GD1AD
NOMESCO Finland
Thorax CT examination
2.4
24.4
213
908
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
3.5
24.3
115
332
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
4.9
24.3
80
165
N02AX02
ATC
tramadol; systemic, rectal
1.4
24.1
1759
14140
R4190
NOMESCO Finland
Nutritional therapy
2.9
24.0
150
528
C83
ICD-10 Finland
Non-follicular lymphoma
56.3
24.0
28
5
9652/3-C77.0
ICD-O-3
Hodgkin lymphoma, mixed cellularity, NOS, of lymph nodes of head, face and neck
+∞
24.0
23
*
9823/3-C77.8
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of multiple regions
+∞
24.0
23
*
8480/3-C80.9
ICD-O-3
Mucinous adenocarcinoma of unknown primary site
+∞
24.0
23
*
A98
ICPC
Health maint/preventive medicine
0.7
23.8
3409
37073
1990X
ICD-9 Finland
Malignant neoplasm without specification of site, Disseminated
31.2
23.7
31
10
C83.71
ICD-10 Finland
Burkitt's tumour
125.6
23.6
25
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
5.5
23.5
70
129
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.8
23.2
99
263
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.8
23.2
155
571
JAH20
NOMESCO Finland
Staging laparotomy
54.3
23.0
27
5
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
36.5
23.0
29
8
TGD00
NOMESCO Finland
Needle biopsy of lung
9.1
23.0
48
53
ZX080
NOMESCO Finland
Image guided radiotherapy
3.4
22.7
114
345
N02BE01
ATC
paracetamol; systemic, rectal
1.4
22.6
3616
33053
E83.50
ICD-10 Finland
Hypercalcemia
4.4
22.6
82
187
C80.98
ICD-10 Finland
Malignant tumor without specified localization other specified histology
45.2
22.3
27
6
L01BB05
ATC
fludarabine; systemic
15.8
22.3
36
23
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
5.6
22.1
65
118
8240/3-C80.9
ICD-O-3
Neuroendocrine tumor, NOS, of unknown primary site
+∞
21.9
21
*
A06AD11
ATC
lactulose; oral
1.6
21.6
703
4780
WW200
NOMESCO Finland
Immunization
2.9
21.4
135
480
C84.49
ICD-10 Finland
Peripheral T-cell lymphoma, unspecified cell type
26.5
21.3
29
11
XW1AT
NOMESCO Finland
Biopsy from other organ close to skin with ultrasound quidance
6.5
21.2
55
85
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
21.0
791
5555
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
4.8
21.0
70
147
KA1FN
NOMESCO Finland
Isotope renography
6.2
20.8
56
91
9663/3-C77.1
ICD-O-3
Hodgkin lymphoma, nodular sclerosis, NOS, of intrathoracic lymph nodes
+∞
20.8
20
*
9702/3-C77.9
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph node, NOS
+∞
20.8
20
*
9690/3-C77.4
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
20.8
20
*
2016A
ICD-9 Finland
Hodgkin's disease, Mixed cellularity
+∞
20.8
20
*
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
2.0
20.7
273
1405
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
5.0
20.7
67
136
J01MA14
ATC
moxifloxacin; systemic
1.8
20.6
380
2201
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
7.0
20.6
51
74
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
210.9
20.6
21
*
C83.8
ICD-10 Finland
Other non-follicular lymphoma
210.9
20.6
21
*
H02AB09
ATC
hydrocortisone; systemic
3.1
20.5
113
368
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
5.7
20.5
59
105
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.7
20.5
90
246
C83.34
ICD-10 Finland
Anaplastic large cell lymphoma
32.7
20.2
26
8
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
2.9
20.1
123
430
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
11.3
19.9
37
33
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
6.6
19.9
51
78
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.3
19.9
184
811
8041/3-C80.9
ICD-O-3
Small cell carcinoma, NOS, of unknown primary site
+∞
19.8
19
*
9680/3-C77.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of inguinal region or leg
+∞
19.8
19
*
6103
FHL
Staging laparotomy (to study the reticuloendothelial system)
+∞
19.8
19
*
8249/3-C80.9
ICD-O-3
Neuroendocrine tumor, grade 2 of unknown primary site
+∞
19.8
19
*
9691/3-C77.0
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of head, face and neck
+∞
19.8
19
*
2014A
ICD-9 Finland
Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,""""LYMPHOCYTIC PREDOMINANCE"""",""""NODULAR""""]
+∞
19.8
19
*
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.0
19.8
116
394
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
3.6
19.7
89
249
390
Kela drug reimbursment
Ibrutinib
19.4
19.5
29
15
GEA00
NOMESCO Finland
Mediastinoscopy
7.9
19.4
44
56
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.0
19.4
117
403
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
19.4
750
5287
JN3AD
NOMESCO Finland
Abdominal CT examination
1.8
19.3
324
1822
C80.91
ICD-10 Finland
Malignant tumor without specified localization epidermoid carcinoma
31.4
19.2
25
8
9659/3-C77.3
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of axilla or arm
+∞
18.8
18
*
9705/3-C77.9
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph node, NOS
+∞
18.8
18
*
9699/3-C77.8
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
18.8
18
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
13.4
18.7
32
24
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
18.5
1460
11740
WX110
NOMESCO Finland
Local anesthesy
1.3
18.5
2548
22288
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
11.4
18.4
34
30
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
3.8
18.4
79
212
3AA13
NOMESCO Finland
NA
17.6
18.2
28
16
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
11.0
18.2
34
31
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
8.9
18.1
38
43
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
5.7
17.9
51
90
M05BX04
ATC
denosumab; parenteral
2.1
17.8
216
1075
WVC10
NOMESCO Finland
Subcutaneous infusion of drugs
9.1
17.8
37
41
TAB00
NOMESCO Finland
Lumbar puncture
2.3
17.8
172
773
2015A
ICD-9 Finland
Hodgkin's disease, Nodular sclerosis[MORBUS HODGKIN, NODULAR SCLEROSIS, CELLULAR PHASE]
+∞
17.7
17
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
6.2
17.5
47
77
Z52.89
ICD-10 Finland
Donor of other organ or tissue
28.9
17.4
23
8
D69.5
ICD-10 Finland
Secondary thrombocytopenia
7.6
17.3
40
53
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
13.9
17.2
29
21
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
3.4
17.2
84
251
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
5.1
17.2
54
107
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
50.2
17.0
20
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
12.1
16.8
30
25
9651/3-C77.9
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph node, NOS
+∞
16.7
16
*
9690/3-C77.0
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of head, face and neck
+∞
16.7
16
*
C84.4
ICD-10 Finland
Peripheral T-cell lymphoma, not elsewhere classified
35.1
16.6
21
6
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
7.1
16.5
40
57
PJ4AT
NOMESCO Finland
Labeling lymphnode with ultrasound guidance
27.6
16.5
22
8
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
13.4
16.4
28
21
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
13.4
16.4
28
21
H01CB02
ATC
octreotide; parenteral
10.8
16.4
31
29
EMB10
NOMESCO Finland
Tonsillectomy
2.3
16.4
153
680
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
2.2
16.0
168
787
9101
FHL
Bone biopsy
14.5
15.8
26
18
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.6
15.7
400
2546
8020/3-C80.9
ICD-O-3
Carcinoma, undifferentiated, NOS, of unknown primary site
+∞
15.6
15
*
9680/3-C77.3
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of axilla or arm
+∞
15.6
15
*
9702/3-C77.8
ICD-O-3
Mature T-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
15.6
15
*
9670/3-C77.0
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of head, face and neck
+∞
15.6
15
*
1512
Kela drug reimbursment
Ibrutinib
17.2
15.6
24
14
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
4.7
15.6
52
111
N05CF01
ATC
zopiclone; oral
1.3
15.5
1328
10748
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
4.4
15.5
55
125
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
7.4
15.4
36
49
WF099
NOMESCO Finland
Other radiotherapy
5.6
15.4
44
79
ED1AA
NOMESCO Finland
Mandipular X-ray examination
5.0
15.3
48
96
A04AA03
ATC
tropisetron; systemic
8.0
15.3
34
43
C43.99
ICD-10 Finland
Unspecified localization of malignant melanoma of the skin other or unspecified histology
8.0
15.3
34
43
B01AB04
ATC
dalteparin; parenteral
1.9
15.2
215
1137
J02AC03
ATC
voriconazole; systemic
8.7
15.2
32
37
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
9.2
15.1
31
34
C76.8
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Overlapping lesion of other and ill-defined sites
23.4
15.1
21
9
L01XE27
ATC
[U] ibrutinib; oral
20.1
15.1
22
11
WX402
NOMESCO Finland
General anaesthesia
1.5
15.0
578
4056
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
6.6
15.0
38
58
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.8
15.0
246
1371
1CX01
NOMESCO Finland
NA
14.0
15.0
25
18
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
5.0
15.0
47
94
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
9.4
14.9
30
32
WX302
NOMESCO Finland
Thoracal epidural anesthesy
1.9
14.7
215
1151
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
4.9
14.6
47
97
I42.7
ICD-10 Finland
Cardiomyopathy due to drugs and other external agents
36.1
14.4
18
5
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
14.4
369
2355
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
2.5
14.3
112
455
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
9.4
13.9
28
30
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.6
13.9
384
2495
R06AE07
ATC
cetirizine; oral
1.3
13.8
1485
12367
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.7
13.8
275
1636
C84.5
ICD-10 Finland
Other mature T/NK-cell lymphomas
23.8
13.8
19
8
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.4
13.6
114
482
9651/3-C77.0
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph nodes of head, face and neck
+∞
13.5
13
*
9659/3-C77.0
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of head, face and neck
+∞
13.5
13
*
J01DB01
ATC
cefalexin; oral
1.3
13.5
3257
30022
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.3
13.5
125
555
UJC20
NOMESCO Finland
Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck
34.1
13.5
17
5
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
13.3
685
5082
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
3.5
13.3
61
176
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
3.7
13.2
57
156
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.1
13.2
72
236
Z51.0
ICD-10 Finland
Radiotherapy session
3.1
13.2
71
231
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
5.8
13.1
36
62
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
3.3
13.1
64
194
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.3
13.1
1237
10111
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
16.7
13.0
20
12
120
Kela drug reimbursment
Hypogammaglobulinaemia
13.0
12.9
22
17
A02BC01
ATC
omeprazole; systemic
1.3
12.8
1124
9084
V03AF03
ATC
calcium folinate; systemic
6.9
12.8
31
45
Z51.88
ICD-10 Finland
Other specified medical care
2.6
12.8
92
357
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
12.7
1268
10435
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
3.8
12.7
52
137
C85.0
ICD-10 Finland
Lymphosarcoma
70.0
12.6
14
*
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
12.3
12.6
22
18
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.1
12.6
69
228
9650/3-C77.8
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of multiple regions
+∞
12.5
12
*
8000/3-C76.2
ICD-O-3
Neoplasm, malignant of abdomen, NOS
+∞
12.5
12
*
9670/3-C80.9
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of unknown primary site
+∞
12.5
12
*
C76.7
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Other ill-defined sites
+∞
12.5
12
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
17.3
12.5
19
11
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
8.7
12.5
26
30
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
3.7
12.5
53
144
127
Kela drug reimbursment
Transplant complication
3.1
12.3
66
214
UJC01
NOMESCO Finland
Scopy of lower throat
3.4
12.3
59
177
B02.9
ICD-10 Finland
Zoster without complication
1.7
12.3
233
1364
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.3
12.2
108
471
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.0
12.1
149
752
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
18.1
12.0
18
10
L01EL01
ATC
ibrutinib; oral
21.3
12.0
17
8
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
13.4
11.9
20
15
PJ2CT
NOMESCO Finland
Biopsy of lymphnode with CT guidance
46.8
11.9
14
*
EP3AT
NOMESCO Finland
Neck soft tissue biopsy with ultrasound guidance
46.8
11.9
14
*
192
Kela drug reimbursment
Fulvestrant
7.9
11.8
26
33
L02BA03
ATC
fulvestrant; parenteral
7.0
11.8
28
40
JFB00
NOMESCO Finland
Partial resection of small intestine
2.7
11.7
81
308
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
16.4
11.6
18
11
I89.9
ICD-10 Finland
Noninfective disorder of lymphatic vessels and lymph nodes, unspecified
12.5
11.6
20
16
C83.70
ICD-10 Finland
Non-Hodgkin's lymphoma of the Burkitt type
65.1
11.6
13
*
WX002
NOMESCO Finland
Sedation and analgesia
1.4
11.6
750
5777
UJF32
NOMESCO Finland
Coloscopy
1.3
11.6
1018
8213
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
11.1
11.5
21
19
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.8
11.5
201
1146
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
5.1
11.5
35
69
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
6.2
11.5
30
49
9698/3-C77.0
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of head, face and neck
+∞
11.5
11
*
9590/3-C77.9
ICD-O-3
Malignant lymphoma, NOS, of lymph node, NOS
+∞
11.5
11
*
9695/3-C77.4
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of inguinal region or leg
+∞
11.5
11
*
8140/3-C76.2
ICD-O-3
Adenocarcinoma, NOS, of abdomen, NOS
+∞
11.5
11
*
PJ002
NOMESCO Finland
Radical radiotherapy of neck, clavicle and axilla
+∞
11.5
11
*
9690/3-C77.2
ICD-O-3
Follicular lymphoma, NOS, of intra-abdominal lymph nodes
+∞
11.5
11
*
C83.6
ICD-10 Finland
Undifferentiated (diffuse) non-Hodgkin's lymphoma
+∞
11.5
11
*
9695/3-C77.0
ICD-O-3
Follicular lymphoma, grade 1 of lymph nodes of head, face and neck
+∞
11.5
11
*
4704
FHL
Neck tumor removal
13.6
11.4
19
14
C83.40
ICD-10 Finland
Immunoblast large cell lymphoma
120.3
11.4
12
*
20013
ICD-8 Finland
Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco alio (lymphonodis intrathoracalibus et intra-abdominalibus inclusis)
120.3
11.4
12
*
WW200
SPAT
NA
0.5
11.4
119
2147
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
3.1
11.3
62
205
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
5.2
11.3
34
66
D77
ICPC
Malignant digestive neopl other/NOS
5.5
11.3
32
58
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
8.3
11.3
24
29
C76.1
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Thorax
20.1
11.1
16
8
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.8
11.0
197
1134
EBA15
NOMESCO Finland
Extraction of large number of teeth
1.9
11.0
153
808
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
6.6
10.9
27
41
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
3.6
10.9
48
135
ZXA00
NOMESCO Finland
Right side
1.3
10.9
1067
8721
C83.51
ICD-10 Finland
B-lymphoblastic lymphoma or leukemia
43.4
10.9
13
*
R11
ICD-10 Finland
Nausea and vomiting
1.6
10.8
290
1872
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
11.9
10.8
19
16
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
15.5
10.8
17
11
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
2.6
10.8
79
311
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
3.1
10.7
56
180
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
28.1
10.7
14
5
NK6AN
NOMESCO Finland
Total body bone isotope imaging
2.0
10.7
130
654
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
5.2
10.7
32
62
372
Kela drug reimbursment
Idelalisib
21.5
10.7
15
7
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.3
10.6
92
398
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
12.9
10.6
18
14
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
3.1
10.6
56
182
E34.0
ICD-10 Finland
Carcinoid syndrome
8.0
10.6
23
29
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
5.3
10.5
31
59
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
5.7
10.5
29
51
5702
FHL
Local lymph node removal (eg armpit, groin)
5.7
10.5
29
51
6753
FHL
Transabdominal splenectomy
14.2
10.5
17
12
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
6.5
10.5
26
40
C83.5
ICD-10 Finland
Lymphoblastic (diffuse) lymphoma
110.2
10.4
11
*
9670/3-C77.8
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of multiple regions
+∞
10.4
10
*
9591/3-C80.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of unknown primary site
+∞
10.4
10
*
9691/3-C77.4
ICD-O-3
Follicular lymphoma, grade 2 of lymph nodes of inguinal region or leg
+∞
10.4
10
*
C83.41
ICD-10 Finland
Immunoblastic (diffuse)
+∞
10.4
10
*
C10AA07
ATC
rosuvastatin; oral
0.7
10.4
562
7274
C83.59
ICD-10 Finland
Lymphoblastic lymphoma of indeterminate type
32.6
10.3
13
*
PJD51
NOMESCO Finland
Block dissection of cervical lymph nodes
8.2
10.3
22
27
N02AA01
ATC
morphine; systemic, rectal
2.6
10.3
73
284
N05BA06
ATC
lorazepam; systemic, sublingual
1.7
10.2
204
1217
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
1.9
10.2
138
722
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
3.3
10.1
49
150
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.2
10.1
101
468
JAL00
NOMESCO Finland
Biopsy of peritoneum
4.9
10.0
31
63
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
7.2
10.0
23
32
C84.41
ICD-10 Finland
Peripheral T-cell lymphoma, medium-sized cell type
40.1
10.0
12
*
N06DX01
ATC
memantine; oral
0.6
9.9
108
1923
P20
ICPC
Memory disturbance
0.7
9.9
266
3860
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
1.9
9.9
142
762
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.8
9.9
161
900
23999
ICD-8 Finland
Neoplasm of unspecified nature of other and unspecified organs, Other and unspecified sites
26.1
9.8
13
5
ENA10
NOMESCO Finland
Biopsy of pharynx
5.9
9.8
26
44
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.0
9.7
118
594
ZX114
NOMESCO Finland
Intramuscular
2.9
9.7
58
205
EMA10
NOMESCO Finland
Biopsy of tonsil
6.5
9.7
24
37
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
3.7
9.7
40
108
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
5.8
9.6
26
45
EBA10
NOMESCO Finland
Surgical removal of tooth
1.5
9.6
327
2232
121
Kela drug reimbursment
Severe hypofunction of sexual glands
2.7
9.6
63
236
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.1
9.6
50
162
A05AA02
ATC
ursodeoxycholic acid; oral
2.8
9.5
58
208
A49.8
ICD-10 Finland
Other bacterial infections of unspecified site
3.5
9.5
43
125
ZX121
NOMESCO Finland
Central venous catheter
5.7
9.5
26
46
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.7
9.5
212
1308
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
4.2
9.4
34
81
9670/3-C77.3
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of axilla or arm
+∞
9.4
9
*
1XC12
NOMESCO Finland
NA
+∞
9.4
9
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
C26.0
ICD-10 Finland
Malignant neoplasm: Intestinal tract, part unspecified
12.3
9.3
16
13
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.6
9.3
210
1300
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
8.7
9.3
19
22
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.4
9.2
77
330
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
2.5
9.1
67
269
ZXA05
NOMESCO Finland
Left side
1.3
9.1
987
8155
L01AA01
ATC
cyclophosphamide; systemic
4.3
9.1
32
75
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
5.1
9.1
27
53
C84.43
ICD-10 Finland
Peripheral T-cell lymphoma, large cell type
36.7
9.0
11
*
Z51.3
ICD-10 Finland
Blood transfusion (without reported diagnosis)
9.0
9.0
18
20
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
9.0
896
7318
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
5.0
8.9
27
54
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
2.4
8.9
74
314
C76.0
ICD-10 Finland
Malignant neoplasm of other and ill-defined sites: Head, face and neck
24.0
8.9
12
5
5701
FHL
Local exploration of lymph nodes (includes biopsy)
24.0
8.9
12
5
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
1.9
8.9
122
645
N17.9
ICD-10 Finland
Acute renal failure, unspecified
1.7
8.9
165
964
N03AX16
ATC
pregabalin; oral
1.3
8.9
836
6777
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
2.4
8.8
70
290
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.1
8.8
92
437
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
2.4
8.7
67
276
KA3EB
NOMESCO Finland
Antegrade pyelography
4.2
8.7
31
74
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
2.1
8.6
89
420
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.6
8.6
97
1713
SPAT1109
SPAT
Analgesia with portable analgesic pump
3.9
8.6
33
84
K85
ICPC
Elevated blood pressure
0.7
8.6
311
4285
D76.1
ICD-10 Finland
Haemophagocytic lymphohistiocytosis
27.5
8.5
11
*
H03AA01
ATC
levothyroxine sodium; systemic
1.3
8.5
762
6139
C26.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of digestive system
20.0
8.5
12
6
L01XX47
ATC
[U] idelalisib; oral
20.0
8.5
12
6
K83.1
ICD-10 Finland
Obstruction of bile duct
2.6
8.4
58
223
A41.8
ICD-10 Finland
Other specified sepsis
2.2
8.4
80
365
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
5.6
8.4
23
41
Z31.8
ICD-10 Finland
Other procreative management
90.2
8.4
9
*
7842A
ICD-9 Finland
Symptoms involving head and neck, Swelling, mass, or lump in head and neck
12.8
8.4
14
11
TJA10
NOMESCO Finland
Laparocentesis
6.7
8.3
20
30
9590/3-C80.9
ICD-O-3
Malignant lymphoma, NOS, of unknown primary site
+∞
8.3
8
*
C83.4
ICD-10 Finland
Immunoblastic (diffuse) non-Hodgkin's lymphoma
+∞
8.3
8
*
9651/3-C77.8
ICD-O-3
Hodgkin lymphoma, lymphocyte-rich of lymph nodes of multiple regions
+∞
8.3
8
*
9699/3-C80.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of unknown primary site
+∞
8.3
8
*
9695/3-C77.2
ICD-O-3
Follicular lymphoma, grade 1 of intra-abdominal lymph nodes
+∞
8.3
8
*
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.6
8.3
167
2572
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
4.0
8.3
31
77
A07AA09
ATC
vancomycin; oral
2.7
8.3
54
202
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.2
8.3
81
373
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
4.0
8.2
31
78
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
1.8
8.1
133
746
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
4.5
8.1
27
60
B74
ICPC
Malignant neoplasm blood other
7.5
8.1
18
24
JDE00
NOMESCO Finland
Gastrojejunostomy
5.7
8.1
22
39
362
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
11.7
8.1
14
12
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
11.7
8.1
14
12
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
3.2
8.0
39
121
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.1
8.0
84
398
167
Kela drug reimbursment
Dabrafenib, trametinib and vemurafenib
10.0
8.0
15
15
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
10.0
8.0
15
15
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.3
8.0
653
5194
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
4.0
7.9
30
76
L01AX03
ATC
temozolomide; systemic
3.8
7.9
31
81
GEB30
NOMESCO Finland
Mediastinotomy and excision of lesion
13.0
7.9
13
10
7893A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal or pelvic swelling, mass, or lump
13.0
7.9
13
10
C10AA05
ATC
atorvastatin; oral
0.8
7.9
1170
13511
TPH07
NOMESCO Finland
Cathetrisation of artery
1.4
7.9
383
2809
D11.70
ICD-10 Finland
Gland sublingual
5.7
7.8
21
37
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
3.2
7.8
39
124
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
8.4
7.8
16
19
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
10.8
7.8
14
13
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
9.4
7.8
15
16
N06DA03
ATC
rivastigmine; oral, transdermal
0.5
7.7
50
1036
UDQ22
NOMESCO Finland
Microlaryngoscopy
3.0
7.7
41
136
B73
ICPC
Leukaemia
7.4
7.7
17
23
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
3.0
7.6
40
132
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
18.4
7.6
11
6
9680/3-C42.1
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of bone marrow
18.4
7.6
11
6
SPAT1255
SPAT
Intravenous administration of medicine
1.5
7.6
244
1647
8140/3-C26.9
ICD-O-3
Adenocarcinoma, NOS, of gastrointestinal tract, NOS
11.8
7.6
13
11
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
1.8
7.6
115
633
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
3.0
7.5
41
139
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.3
7.5
68
304
C50.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of breast
7.1
7.5
17
24
C50.99
ICD-10 Finland
Breast, unspecified
2.1
7.4
83
408
SAA03
NOMESCO Finland
Extended examination of mouth
1.2
7.4
1196
10293
2002A
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Burkitt's tumour or lymphoma
80.2
7.4
8
*
C83.7
ICD-10 Finland
Burkitt lymphoma
80.2
7.4
8
*
L01CA04
ATC
vinorelbine; systemic
3.2
7.4
37
118
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
3.3
7.4
34
102
B59
ICD-10 Finland
Pneumocystosis
13.4
7.4
12
9
BA2AT
NOMESCO Finland
Biopsy of thyroid with ultrasound quidance
13.4
7.4
12
9
9109
FHL
Other measure in this category
7.6
7.4
16
21
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
7.6
7.4
16
21
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
2.7
7.4
48
181
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
2.7
7.4
47
173
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
5.6
7.4
20
36
G62.0
ICD-10 Finland
Drug-induced polyneuropathy
5.6
7.4
20
36
UJK02
NOMESCO Finland
ERCP
1.9
7.3
101
535
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
2.8
7.3
44
159
9687/3-C77.9
ICD-O-3
Burkitt lymphoma, NOS, of lymph node, NOS
+∞
7.3
7
*
9705/3-C77.8
ICD-O-3
Angioimmunoblastic T-cell lymphoma of lymph nodes of multiple regions
+∞
7.3
7
*
9691/3-C77.2
ICD-O-3
Follicular lymphoma, grade 2 of intra-abdominal lymph nodes
+∞
7.3
7
*
9823/3-C77.0
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph nodes of head, face and neck
+∞
7.3
7
*
9650/3-C77.3
ICD-O-3
Hodgkin lymphoma, NOS, of lymph nodes of axilla or arm
+∞
7.3
7
*
9702/3-C80.9
ICD-O-3
Mature T-cell lymphoma, NOS, of unknown primary site
+∞
7.3
7
*
9688/3-C77.9
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph node, NOS
+∞
7.3
7
*
C85
ICD-10 Finland
Other and unspecified types of non-Hodgkin lymphoma
+∞
7.3
7
*
9688/3-C77.8
ICD-O-3
T-cell/histiocyte rich large B-cell lymphoma of lymph nodes of multiple regions
+∞
7.3
7
*
9659/3-C77.4
ICD-O-3
Hodgkin lymphoma, nodular lymphocyte predominant of lymph nodes of inguinal region or leg
+∞
7.3
7
*
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
10.9
7.3
13
12
C07.70
ICD-10 Finland
Malignant tumor of the superficial part of the parotid gland
10.9
7.3
13
12
XW4CT
NOMESCO Finland
Biopsy of other inner organ with CT guidance
9.4
7.3
14
15
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.8
7.2
114
636
6BA02
NOMESCO Finland
NA
5.4
7.2
20
37
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
2.7
7.2
46
170
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
2.2
7.1
68
312
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.8
7.1
521
6502
SPAT1053
SPAT
Memory test
0.8
7.1
390
5054
X77
ICPC
Malignant neopl genital female other
7.9
7.1
15
19
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
7.1
349
2566
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
4.0
7.1
26
65
L13
ICPC
Hip symptom/complaint
0.7
7.0
320
4259
C79.2
ICD-10 Finland
Secondary malignant neoplasm of skin
8.8
7.0
14
16
A02BA02
ATC
ranitidine; systemic
1.3
7.0
751
6176
R06.0
ICD-10 Finland
Dyspnoea
1.2
7.0
917
7713
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
4.7
7.0
22
47
EP1CM
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with 3 Tesla magnet
7.0
7.0
16
23
J01MA02
ATC
ciprofloxacin; systemic
1.2
7.0
1516
13416
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
2.6
6.9
46
176
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
3.6
6.9
29
81
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
3.7
6.9
28
76
L01XE25
ATC
[U] trametinib; oral
13.8
6.9
11
8
BA1AE
NOMESCO Finland
Thyroiid ultrasound examination
2.4
6.8
52
214
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
1.9
6.8
91
482
J02AC01
ATC
fluconazole; systemic
1.2
6.8
1155
9986
C48.19
ICD-10 Finland
Malignant tumor in specified location in peritoneum other or unspecified histlogy
40.1
6.8
8
*
J45
ICD-10 Finland
Asthma
0.6
6.7
137
2097
J94.9
ICD-10 Finland
Pleural condition, unspecified
3.2
6.7
32
100
J70.4
ICD-10 Finland
Drug-induced interstitial lung disorders, unspecified
22.5
6.7
9
*
M25.5
ICD-10 Finland
Pain in joint
0.8
6.6
601
7324
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
4.4
6.6
22
50
WX892
NOMESCO Finland
Monitored bed care
1.4
6.6
271
1928
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
12.2
6.6
11
9
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
12.2
6.6
11
9
R50.8
ICD-10 Finland
Other specified fever
3.5
6.6
28
80
N05BA04
ATC
oxazepam; oral
1.2
6.6
834
6990
L01XE21
ATC
[U] regorafenib; oral
8.7
6.5
13
15
F03
ICD-10 Finland
Unspecified dementia
0.6
6.5
77
1337
L01XE23
ATC
[U] dabrafenib; oral
10.0
6.5
12
12
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
4.3
6.5
22
51
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.8
6.5
39
142
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
1.6
6.5
163
1043
L02AE03
ATC
goserelin; implant
2.3
6.5
55
239
B03XA02
ATC
darbepoetin alfa; parenteral
2.0
6.4
75
375
L01XE33
ATC
[U] palbociclib; oral
5.7
6.4
17
30
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.1
6.4
32
103
UDQ02
NOMESCO Finland
Direct laryngoscopy
3.0
6.4
33
109
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
4.0
6.4
23
57
R70.0
ICD-10 Finland
Elevated erythrocyte sedimentation rate
1.9
6.4
81
421
C09CA01
ATC
losartan; oral
0.8
6.3
635
7651
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
2.9
6.3
34
116
115
Kela drug reimbursment
Breast cancer
1.5
6.3
220
1517
J94.0
ICD-10 Finland
Chylous effusion
11.0
6.3
11
10
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
11.0
6.3
11
10
H61.2
ICD-10 Finland
Impacted cerumen
0.6
6.3
77
1322
Z08.9
ICD-10 Finland
Follow-up examination after unspecified treatment for malignant neoplasm
3.8
6.3
24
63
8000/3-C76.1
ICD-O-3
Neoplasm, malignant of thorax, NOS
+∞
6.2
6
*
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.2
6
*
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.2
6
*
2017X
ICD-9 Finland
Hodgkin's disease, Lymphocytic depletion[MORBUS HODGKIN, LYMPHOCYTIC DEPLETION NUD]
+∞
6.2
6
*
20228
ICD-8 Finland
Other neoplasms of lymphoid tissue, Other primary malignant neoplasms of lymphoid tissue
+∞
6.2
6
*
9698/3-C77.4
ICD-O-3
Follicular lymphoma, grade 3 of lymph nodes of inguinal region or leg
+∞
6.2
6
*
C88.4
ICD-10 Finland
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
+∞
6.2
6
*
C84.42
ICD-10 Finland
Peripheral T-cell lymphoma, both medium and large cell type
+∞
6.2
6
*
9690/3-C77.3
ICD-O-3
Follicular lymphoma, NOS, of lymph nodes of axilla or arm
+∞
6.2
6
*
C779, 9715, 3
ICD-O-3
NA
+∞
6.2
6
*
3AF07
NOMESCO Finland
NA
+∞
6.2
6
*
9670/3-C77.4
ICD-O-3
Malignant lymphoma, small B lymphocytic, NOS, of lymph nodes of inguinal region or leg
+∞
6.2
6
*
PJ3HT
NOMESCO Finland
Cytology of deep lymphnode with ultrasound guidance
+∞
6.2
6
*
20018
ICD-8 Finland
Lymphosarcoma and reticulum-cell sarcoma, Lymphosarcoma loco non indicato sive generalisatum
+∞
6.2
6
*
2014X
ICD-9 Finland
Hodgkin's disease, Lymphocytic-histiocytic predominance[MORBUS HODGKIN,LYMPHOCYTIC PREDOMINANCE"""",NUD]
+∞
6.2
6
*
L01XB01
ATC
procarbazine; oral
+∞
6.2
6
*
1DB01
NOMESCO Finland
NA
26.7
6.2
8
*
C83.52
ICD-10 Finland
T-lymphoblastic lymphoma or leukemia
26.7
6.2
8
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
2.7
6.2
38
140
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.8
6.2
406
5140
NF3AA
NOMESCO Finland
Femur X-ray examination
2.0
6.2
73
367
104
Kela drug reimbursment
Thyroid insufficiency
1.5
6.2
233
1632
H25.1
ICD-10 Finland
Senile nuclear cataract
0.8
6.2
804
9442
SPAT1088
SPAT
Blood transfusion
3.2
6.2
29
90
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
2.3
6.2
54
241
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
4.5
6.1
20
45
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
5.3
6.1
17
32
A09AA02
ATC
multienzymes (lipase, protease etc.)
2.0
6.1
75
385
R4110
NOMESCO Finland
Physiotherapy
1.2
6.1
923
7870
1501
Kela drug reimbursment
Palbociclib
4.2
6.1
21
50
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
4.2
6.1
21
50
K86
ICPC
Hypertension uncomplicated
0.7
6.1
248
3357
H01CB03
ATC
lanreotide; parenteral
4.6
6.1
19
41
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.7
6.1
251
3388
TK800
NOMESCO Finland
Hemodialysis
1.9
6.0
81
431
C43.9
ICD-10 Finland
Malignant neoplasm: Malignant melanoma of skin, unspecified
6.7
6.0
14
21
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.7
6.0
196
2746
Z01.8
ICD-10 Finland
Other specified special examinations
1.2
6.0
716
5956
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
2683
13895
2.95
311.64
8.9
5.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
1511
3586
5.55
307.65
1.5
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1637
4943
4.39
307.65
1.6
1.7
—
—
—
0
0
(4035726)
1613
3530
6.20
307.65
1.6
1.4
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
581
460
14.11
307.65
1.5
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
369
229
17.28
307.65
2.3
1.9
%
14.6
15.5
0.29
155
89
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1335
2241
7.70
307.65
1.4
1.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3630
21633
3.31
307.65
14.6
6.1
umol/l
12.3
12.0
0.30
3560
20473
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
294
205
15.15
307.65
3.0
2.2
e9/l
0.2
0.2
0.17
252
183
(1175426) CD3 cells/100 lymphocytes in Blood
371
236
16.87
307.65
2.3
1.9
%
73.2
71.0
0.97
354
221
(40768795) Lymph node Pathology biopsy report
904
287
38.02
307.65
1.5
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
564
754
8.28
307.65
1.6
1.5
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
308
217
15.04
307.65
2.8
2.2
e9/l
0.4
0.1
0.74
303
208
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
369
219
18.08
307.65
2.3
1.9
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
572
231
27.74
307.65
1.4
1.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
478
560
9.31
307.65
2.7
2.6
u/ml
18587.4
1464.9
0.95
55
37
(3011412) CD3 cells [#/volume] in Blood
473
312
16.60
307.65
2.7
2.1
e9/l
1.0
1.1
0.31
310
176
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
302
216
14.79
307.65
2.9
2.2
e6/l
543.4
504.2
0.30
251
184
(21494815) CD4 cells/100 lymphocytes in Specimen
334
267
13.31
307.65
2.3
2.1
%
27.8
42.2
3.78
33
40
(3005719) IgG [Mass/volume] in Serum or Plasma
1075
2843
4.52
307.65
3.8
2.6
g/l
8.8
10.7
26.04
1022
2567
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
525
722
7.99
307.65
4.9
5.4
iu/ml
506.2
2704.3
0.53
78
105
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2376
5086
7.83
307.65
7.4
3.9
u/l
265.4
243.6
4.61
2298
4776
(40765096) Chromosome analysis panel by Banding
266
106
26.41
307.65
1.2
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
1561
4181
4.93
307.65
1.5
1.6
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
3177
18219
2.95
301.46
9.2
5.9
%
0.6
0.7
0.83
3046
16885
(3019069) Monocytes/100 leukocytes in Blood
3235
18828
2.94
296.77
9.8
6.2
%
9.4
8.9
12.24
3108
17498
(3006504) Eosinophils/100 leukocytes in Blood
3222
18733
2.93
295.76
9.4
5.9
%
2.6
2.9
6.01
3094
17342
(3013650) Neutrophils [#/volume] in Blood by Automated count
3683
23218
3.07
287.04
21.8
8.5
e9/l
3.9
4.3
14.63
3457
20082
(3002030) Lymphocytes/100 leukocytes in Blood
3253
19237
2.89
284.94
9.6
6.0
%
25.5
26.7
5.89
3122
17757
(3006315) Basophils [#/volume] in Blood
3320
20033
2.86
276.29
8.9
5.6
e9/l
0.0
0.0
4.81
3060
17100
(3001604) Monocytes [#/volume] in Blood
3305
19919
2.85
275.24
8.9
5.6
e9/l
0.6
0.6
2.27
3047
16987
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
275
237
12.20
270.75
3.1
2.1
e6/l
397.0
635.4
4.95
125
107
(3019198) Lymphocytes [#/volume] in Blood
3349
20440
2.84
270.01
9.0
5.7
e9/l
1.9
1.9
0.02
3106
17740
(3018010) Neutrophils/100 leukocytes in Blood
3177
18966
2.77
265.88
8.9
5.8
%
58.2
58.1
0.02
3051
17606
(3013115) Eosinophils [#/volume] in Blood
3361
20669
2.81
264.84
9.6
5.8
e9/l
0.2
0.2
10.71
3108
17895
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1636
6974
2.98
263.48
5.9
3.2
mmol/l
0.8
0.8
4.08
1575
6451
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
429
690
6.69
257.43
1.3
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
241
188
13.40
252.21
3.6
2.4
%
35.7
38.2
0.56
102
65
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
383
603
6.78
234.23
1.4
1.4
u/ml
111.7
118.5
0.26
90
118
(3024561) Albumin [Mass/volume] in Serum or Plasma
3045
18536
2.58
232.56
7.6
4.8
g/l
33.2
34.9
39.40
2927
17094
(21494814) CD8 cells/100 lymphocytes in Specimen
201
134
15.57
229.75
2.2
2.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
776
2261
3.87
229.65
2.8
1.8
g/l
1.2
1.4
0.85
718
2032
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
472
943
5.41
225.50
1.3
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
185
110
17.41
224.22
2.2
1.9
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
2116
11044
2.56
221.52
5.4
2.8
umol/l
1974.5
5650.5
6.10
2003
9390
(3023368) Bacteria identified in Blood by Culture
2306
12572
2.51
219.34
6.9
4.3
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
171
98
18.02
210.92
2.3
1.9
%
36.1
26.6
5.70
156
90
(3006245) CD3-CD19+ cells/100 cells in Blood
171
100
17.65
208.87
2.3
2.0
%
8.0
10.4
1.07
149
89
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1156
4615
2.94
203.41
3.6
4.0
ug/l
61.8
22.7
2.92
972
3815
(3017181) Myelocytes/100 leukocytes in Blood
939
3476
3.08
187.83
5.4
4.0
%
1.1
0.9
0.98
548
1008
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
455
1029
4.75
187.28
2.1
1.6
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
444
989
4.82
186.14
2.2
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
373
727
5.45
182.45
4.0
3.5
%
1.7
1.5
0.35
308
542
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
374
757
5.25
175.24
2.2
1.7
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
153
112
14.05
165.80
3.1
1.8
u/l
47.0
58.4
0.19
148
104
(3027945) Reticulocytes/100 erythrocytes in Blood
1181
5398
2.54
154.85
3.4
2.4
%
1.8
1.8
0.06
1086
4734
(3000060) B lymphocytes [#/volume] in Blood
120
65
18.88
151.76
2.2
1.9
e6/l
102.5
183.3
1.45
44
33
(3021440) Promyelocytes/100 leukocytes in Blood
847
3308
2.87
151.52
5.4
4.1
%
0.2
0.1
1.54
505
940
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
326
664
5.17
151.34
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
392
930
4.48
151.33
1.3
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
524
1554
3.64
148.48
2.4
2.6
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
225
333
7.02
145.12
1.6
1.8
mg/l
3.6
4.7
2.97
216
316
(40760892) CBC W Ordered Manual Differential panel - Blood
1552
8239
2.27
143.52
7.4
4.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
3106
21536
2.12
143.15
9.9
6.9
mmol/l
1.2
1.2
8.60
2523
18093
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
215
313
7.13
140.76
1.6
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2882
19506
2.09
140.74
8.4
6.1
mmol/l
1.2
1.2
9.34
2742
17528
(3002179) Metamyelocytes/100 leukocytes in Blood
797
3157
2.80
137.98
5.2
3.9
%
0.8
0.6
1.05
382
714
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
298
614
5.09
136.34
1.3
1.2
u/ml
282.5
273.6
0.18
185
375
(3023520) Reticulocytes [#/volume] in Blood
925
4069
2.55
129.25
3.5
2.5
e9/l
68.7
68.1
0.19
755
3089
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
570
1946
3.17
128.41
2.2
1.9
ug/l
2.3
2.5
0.10
522
1697
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
402
1096
3.89
128.32
1.6
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
230
403
5.93
125.60
2.3
1.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
127
112
11.60
122.67
3.6
2.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
236
434
5.65
122.45
2.3
1.7
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
365
963
4.00
121.88
1.5
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
2230
14274
1.99
121.06
7.1
3.3
mmol/l
2.3
2.3
0.07
2057
12225
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
271
576
4.91
119.38
2.0
2.0
ug/l
27.1
23.9
0.42
265
566
(3032080) INR in Blood by Coagulation assay
2664
18200
1.96
118.89
9.9
10.4
inr
1.3
1.3
3.11
717
5049
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
305
723
4.42
117.41
1.7
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
240
477
5.23
114.24
4.3
4.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
2077
13202
1.96
112.88
3.8
2.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3978
31558
2.16
112.72
18.1
7.5
u/l
101.8
79.7
34.51
3876
29552
(3003458) Phosphate [Moles/volume] in Serum or Plasma
1131
5750
2.24
112.32
6.4
5.9
mmol/l
1.0
1.0
0.45
1083
5301
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
266
587
4.72
111.94
1.7
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
156
207
7.74
110.77
3.9
3.2
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
344
941
3.85
108.96
3.4
3.3
u/ml
1763.9
733.9
1.03
311
861
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
474
1594
3.17
108.94
2.4
3.3
u/ml
3188.2
3002.9
0.03
382
1357
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
258
573
4.69
107.69
1.7
1.4
—
—
—
0
0
(3018418) pH of Serum or Plasma
1992
12675
1.93
106.26
6.7
4.0
ph
7.4
7.4
0.22
551
2385
(3025159) Blasts/100 leukocytes in Blood
724
3092
2.56
106.17
5.4
4.1
%
0.1
0.3
1.02
404
782
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2708
19052
1.89
105.93
6.0
4.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
1156
6089
2.16
104.14
2.0
2.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
189
329
5.93
103.80
2.5
2.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
261
604
4.50
103.46
1.8
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
1670
10132
1.96
101.60
16.6
6.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
182
315
5.95
100.54
1.3
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1403
8072
2.02
99.00
5.6
3.0
mmol/l
2.5
2.5
9.67
1329
7009
(3020630) Protein [Mass/volume] in Serum or Plasma
827
3880
2.35
98.17
2.7
2.6
g/l
64.2
66.1
7.27
776
3485
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
726
3221
2.46
97.65
2.1
1.6
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
263
652
4.20
95.27
1.8
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
722
3243
2.43
94.32
1.9
2.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
259
640
4.21
94.22
2.1
2.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
222
490
4.69
93.27
1.8
1.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
129
168
7.85
93.03
2.8
2.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
120
147
8.33
91.07
1.3
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
126
166
7.76
89.97
2.8
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
126
166
7.76
89.97
2.8
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
1285
7463
1.96
86.46
2.5
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
185
374
5.09
86.23
2.4
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
185
374
5.09
86.23
2.5
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
185
374
5.09
86.23
2.4
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
137
221
6.34
81.20
2.7
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
137
221
6.34
81.20
2.7
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
137
221
6.34
81.20
2.7
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
137
221
6.34
81.20
2.7
1.9
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
109
138
8.05
80.48
1.8
2.2
u/ml
4607.0
24099.7
0.43
16
21
(3032352) Blasts [#/volume] in Cerebral spinal fluid
62
36
17.42
75.65
1.8
1.9
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
96
113
8.64
75.21
1.2
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
193
461
4.31
73.31
4.2
3.5
%
56.1
58.3
0.51
128
279
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
260
770
3.50
72.84
5.4
3.5
%
58.7
58.2
0.20
260
770
(40758292) HTLV I+II Ab panel - Serum
68
52
13.24
71.63
1.6
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
158
340
4.76
68.39
1.3
1.2
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
75
9
84.64
67.12
1.1
1.0
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1531
10126
1.73
64.28
3.6
2.4
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
341
1282
2.78
63.39
1.6
1.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
840
4669
1.96
61.94
4.8
2.7
umol/l
11.8
9.2
1.17
756
4077
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1851
13064
1.65
59.87
3.2
2.6
u/l
53.1
58.8
4.78
1739
12016
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
125
248
5.14
59.51
1.9
1.6
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
135
288
4.79
59.04
1.8
1.5
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1551
10524
1.68
58.05
5.7
4.0
%
86.8
86.1
0.47
1526
10253
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
154
370
4.26
58.03
1.9
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
123
249
5.04
57.22
1.9
1.6
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
1109
6884
1.78
57.14
2.7
2.0
s
29.8
30.0
0.78
1088
6664
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
55
43
12.92
57.13
1.3
1.3
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
734
4017
1.97
56.22
2.1
2.2
g/l
0.2
0.2
11.08
683
3716
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
880
5120
1.87
55.97
2.3
1.8
—
—
—
0
0
(44790048)
169
452
3.83
55.00
1.7
1.4
—
—
—
0
0
(44790047)
169
452
3.83
55.00
1.7
1.4
—
—
—
0
0
(44806118)
169
452
3.83
55.00
1.7
1.4
—
—
—
0
0
(44790049)
169
452
3.83
55.00
1.7
1.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
3075
24844
1.59
54.85
6.6
4.8
mmol/l
6.8
6.8
1.14
2970
23323
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3406
39125
0.62
54.23
4.4
5.2
mmol/l
2.6
2.6
0.12
2990
35498
(3007164) IgA [Mass/volume] in Serum or Plasma
1084
6791
1.76
53.68
2.2
1.5
g/l
2.1
2.6
9.66
834
3983
(40768804) Tissue Pathology biopsy report
2134
15942
1.58
52.66
2.6
2.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
370
1585
2.44
52.49
3.4
3.7
u/ml
158.3
61.2
3.84
361
1527
(3021589) Normoblasts [#/volume] in Blood
2299
17518
1.57
51.73
16.4
10.0
e9/l
0.0
0.0
0.55
1983
14235
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
660
3580
1.97
51.60
7.7
3.9
mmol/l
1.2
1.2
1.38
634
3121
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
56
53
10.67
51.48
1.5
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
216
710
3.13
51.03
1.6
1.5
g/l
33.7
31.4
1.97
209
638
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3139
36585
0.63
50.91
5.8
6.3
mmol/mol
41.0
40.5
1.39
2791
33419
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
100
187
5.43
50.87
1.8
1.6
ug/l
3.2
4.9
0.43
84
153
(40768806) Pleura Pathology biopsy report
183
549
3.42
50.17
1.7
1.6
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
47
36
13.17
49.38
1.5
2.4
mg/l
0.5
1.2
4.40
30
28
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
858
5133
1.81
49.30
2.2
1.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
82
131
6.34
49.08
1.4
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3286
37820
0.64
48.92
4.0
4.6
mmol/l
1.4
1.4
12.16
2907
34249
(40768441) Liver Pathology biopsy report
116
257
4.59
48.47
1.2
1.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3327
38165
0.64
48.43
4.1
4.6
mmol/l
4.5
4.5
0.65
2967
34830
(3012441) Differential panel - Pleural fluid
176
541
3.33
46.43
1.7
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
322
1373
2.44
46.05
1.5
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
262
1016
2.66
45.68
1.3
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
178
559
3.26
45.36
1.1
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
3485
29582
1.55
45.13
6.1
4.1
mm/h
17.6
13.4
28.46
3265
27107
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
278
1129
2.55
44.10
2.9
2.4
g/l
4.0
3.6
2.78
266
1067
(3028308) Erythrocytes [#/volume] in Pleural fluid
176
567
3.18
43.00
1.6
1.5
e6/l
38662.7
71353.2
1.08
116
341
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
102
226
4.58
42.64
1.2
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
186
624
3.06
42.42
1.6
1.5
e6/l
1648.4
1727.6
0.12
146
458
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
177
590
3.07
40.82
6.0
6.5
mg/l
10.8
12.2
4.25
161
544
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
357
1684
2.20
40.26
3.0
3.0
u/ml
0.3
0.3
0.02
231
964
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
172
570
3.09
40.07
1.2
1.1
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
57
77
7.47
39.83
1.2
1.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
153
478
3.27
39.34
1.4
1.3
u/l
363.3
324.2
0.37
145
453
(3003694) ABO and Rh group [Type] in Blood
1428
10274
1.54
38.68
1.5
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
123
347
3.61
37.08
1.6
1.4
u/l
14.9
13.1
1.04
116
331
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
661
10442
0.58
36.85
1.7
1.6
mmol/l
1.5
1.3
2.56
561
8686
(3008536) Aspergillus sp Ab [Presence] in Serum
56
81
6.98
36.83
2.8
1.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
208
802
2.66
36.65
1.6
1.4
u/l
13.6
9.7
2.82
169
646
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
238
982
2.49
36.48
1.8
1.9
mg/l
11.9
12.3
0.26
224
896
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
486
2674
1.90
35.81
1.7
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
732
4584
1.70
34.82
5.5
3.6
—
—
—
0
0
(3012501) Base excess in Blood by calculation
240
1018
2.42
34.65
4.6
4.8
mmol/l
3.0
2.6
1.09
182
695
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
93
226
4.17
34.60
1.6
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
93
226
4.17
34.60
1.6
1.6
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
186
706
2.70
33.82
1.4
1.3
miu/ml
127.1
212.8
1.88
38
290
(3002582) Erythrocytes [#/volume] in Urine
1726
13195
1.46
33.78
3.5
3.4
e6/l
69.7
91.7
0.55
1431
10248
(3020779) Urea [Moles/volume] in Serum or Plasma
676
4177
1.71
33.71
7.2
7.2
mmol/l
9.9
10.8
2.34
647
3952
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
417
2231
1.95
33.35
1.8
1.7
g/l
1.7
1.6
2.10
339
1922
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1652
12554
1.47
33.22
5.9
3.2
u/l
46.0
36.5
1.08
1583
11843
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3243
36539
0.69
32.28
3.8
4.1
mmol/l
1.3
1.3
3.53
2860
32809
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
77
173
4.50
31.70
1.3
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
160
583
2.80
31.47
1.1
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
126
406
3.16
30.83
2.5
1.7
—
—
—
0
0
(3019225) pH of Specimen
698
4463
1.65
30.37
6.9
4.6
—
—
—
0
0
(3026782) Osmolality of Urine
1206
8741
1.50
30.26
3.0
2.9
mosm/kgh2o
548.6
553.3
0.32
1089
7440
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
318
1609
2.04
29.75
1.7
1.8
u/l
41.9
38.5
1.78
281
1388
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1764
13792
1.43
29.61
3.5
3.2
ng/l
1867.6
1726.6
0.63
1567
11929
(3031040) Bacteria [#/volume] in Urine by Automated count
3150
27211
1.41
29.54
5.1
4.8
e6/l
916.9
1844.8
0.80
91
430
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
116
366
3.22
29.41
1.3
1.3
u/l
17.7
11.9
0.89
110
334
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
129
436
3.01
29.11
2.9
3.0
—
—
—
0
0
(3010421) pH of Blood
252
1189
2.18
28.32
4.6
4.6
ph
7.4
7.4
2.33
236
999
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
360
1955
1.90
27.43
2.9
2.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2059
16700
1.39
27.30
4.4
4.0
ng/l
45.0
92.8
0.99
1683
12426
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
48
81
5.97
27.27
1.7
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
564
3509
1.68
27.10
3.2
2.2
nmol/l
371.2
374.4
0.14
534
3191
(3025941) Bacteria identified in Stool by Culture
372
2059
1.87
26.72
1.4
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
116
388
3.04
26.68
1.2
1.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
269
1341
2.06
26.19
1.9
2.3
g/l
0.0
0.0
0.69
248
1215
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
338
1826
1.91
26.15
1.9
2.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1550
12048
1.41
26.12
3.4
3.3
e6/l
0.6
0.5
0.73
1259
9165
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
338
1828
1.91
26.07
1.9
2.3
g/l
7.5
7.4
0.35
252
1333
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
46
78
5.94
26.01
1.6
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
122
426
2.91
26.01
1.1
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
337
1824
1.91
25.93
1.9
2.3
g/l
3.6
3.8
2.06
250
1280
(3018095) Leukocytes [#/volume] in Urine
1875
15069
1.38
25.86
4.0
3.9
e6/l
164.1
108.7
0.67
1487
10926
(3001893) Eosinophils/100 leukocytes in Pleural fluid
67
161
4.20
25.37
1.6
1.4
%
1.8
2.6
0.47
57
132
(3000850) Epithelial cells [#/volume] in Urine
1239
9308
1.44
25.09
2.8
2.7
e6/l
5.5
4.9
0.97
1129
8152
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
294
1538
1.97
25.01
2.0
2.4
g/l
0.7
1.0
1.11
255
1302
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
315
1688
1.92
24.97
2.0
2.4
g/l
3.4
3.1
5.18
254
1311
(3023183) Ammonium ion [Moles/volume] in Plasma
204
932
2.24
24.83
2.0
2.8
umol/l
37.2
35.3
0.39
159
776
(3000012) Reticulocyte production index
83
237
3.54
24.67
1.6
1.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
652
4301
1.59
24.67
4.4
3.8
mmol/l
2.1
1.9
0.71
519
3450
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
24
19
12.69
24.59
1.1
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
694
4654
1.57
24.44
1.6
1.5
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
75
202
3.75
24.30
1.5
1.4
%
64.9
67.3
0.23
66
160
(36304419) Bacteria [Presence] in Urine
1489
11613
1.40
24.21
3.4
3.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
247
1229
2.06
24.17
1.9
2.3
g/l
0.0
0.0
0.00
228
1126
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
293
1555
1.94
23.90
2.1
3.3
mg/l
34.1
59.7
1.92
230
1269
(3034860) Kappa light chains.free [Mass/volume] in Serum
293
1557
1.94
23.81
2.1
3.3
mg/l
56.2
98.4
0.60
233
1268
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
315
1717
1.89
23.70
1.8
2.3
g/l
9.1
10.3
3.24
274
1430
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
248
1251
2.03
23.38
1.9
2.3
g/l
0.0
0.0
0.50
228
1129
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
286
1519
1.93
23.27
2.1
3.3
ratio
9.5
2.3
0.59
21
115
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
222
1077
2.11
23.25
4.4
3.3
mg/l
1.4
1.6
3.65
210
971
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
136
538
2.57
22.84
2.2
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
644
4308
1.57
22.84
4.5
3.8
kpa
5.8
5.8
0.79
630
4159
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
61
148
4.16
22.83
1.4
1.3
ug/l
132.3
362.2
0.56
35
76
(3025468) Yersinia sp identified in Specimen by Organism specific culture
136
539
2.56
22.75
2.2
1.4
—
—
—
0
0
(3009343) pH of Capillary blood
470
2916
1.67
22.68
4.5
3.9
ph
7.4
7.4
0.81
48
352
(3005988) Vibrio sp identified in Specimen by Organism specific culture
136
540
2.56
22.67
2.2
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
769
5359
1.51
22.60
1.4
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
137
548
2.54
22.49
2.2
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
89
283
3.18
22.36
1.3
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
430
2622
1.70
22.13
3.4
3.2
e9/l
4.2
4.2
0.04
314
1938
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
33
47
7.06
22.03
1.2
1.1
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
123
473
2.64
21.89
1.5
1.4
mmol/l
6.3
6.4
0.18
118
441
(3024522) Salmonella sp identified in Specimen by Organism specific culture
135
544
2.52
21.84
2.2
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
187
870
2.19
21.80
1.6
1.4
iu/l
26.0
29.0
0.56
153
734
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
134
539
2.53
21.76
2.2
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
470
2955
1.65
21.51
4.5
3.9
kpa
5.1
5.1
1.01
444
2710
(3023383) Lactate [Moles/volume] in Pleural fluid
61
155
3.97
21.48
1.3
1.3
mmol/l
3.2
3.4
0.17
56
140
(3045788) Cell count panel - Pleural fluid
124
485
2.60
21.34
1.7
1.5
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
265
1414
1.92
21.27
1.9
2.2
g/l
35.7
37.3
3.72
239
1192
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
31
43
7.25
21.18
1.3
1.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
451
2817
1.66
21.17
4.5
3.8
mmol/l
2.0
1.8
0.57
375
2043
(3013862) HLA-DP [Type]
18
11
16.42
21.11
1.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
166
746
2.27
21.06
1.7
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
845
6082
1.47
21.03
2.3
2.7
%
21.9
22.4
0.39
759
5144
(40760888) Immunoglobulin light chains.free panel - Serum
228
1168
2.00
20.61
2.2
3.4
—
—
—
0
0
(44786800) Granulocytes/100 leukocytes in Body fluid
37
64
5.82
20.53
1.4
1.4
%
18.6
21.6
0.21
29
45
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
30
42
7.18
20.33
3.5
5.7
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
30
42
7.18
20.33
1.8
2.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
357
2123
1.73
20.10
4.8
4.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
567
3790
1.56
20.05
7.1
8.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
84
277
3.07
19.89
1.2
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
314
1806
1.79
19.85
2.1
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
194
950
2.08
19.85
1.2
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
48
108
4.48
19.82
1.3
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
206
1033
2.04
19.77
4.0
3.9
—
—
—
0
0
(21494434) Karyotype in Bone marrow
109
417
2.65
19.64
1.1
1.2
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
17
11
15.50
19.35
1.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
17
11
15.50
19.35
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
17
11
15.50
19.35
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
17
11
15.50
19.35
1.0
1.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
879
6484
1.43
19.01
2.3
2.6
g/l
2.2
2.3
6.31
820
5985
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
188
930
2.06
18.74
2.0
1.4
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
930
6957
1.41
18.54
2.3
2.6
umol/l
11.7
12.6
2.82
874
6422
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
309
1806
1.76
18.49
5.1
4.1
mmol/l
25.5
24.8
3.31
294
1647
(3019832) Treponema pallidum Ab [Presence] in Serum
336
2020
1.71
18.18
1.4
1.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
169
815
2.11
18.03
1.8
1.4
e6/l
511.3
1027.3
0.45
142
667
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
169
815
2.11
18.03
1.7
1.4
e6/l
44.5
22.5
0.32
140
631
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
355
2176
1.68
17.87
5.1
4.0
mmol/l
24.2
24.1
0.32
333
1942
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
85
304
2.83
17.46
1.8
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
185
939
2.01
17.20
1.7
1.3
mg/l
537.7
536.3
0.01
175
879
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
86
314
2.77
17.01
1.7
1.5
nmol/l
0.3
0.3
0.32
75
248
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
192
996
1.96
16.79
1.5
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
192
996
1.96
16.79
1.5
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
172
859
2.04
16.73
1.5
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
83
301
2.79
16.64
1.8
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
42
98
4.31
16.61
1.1
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
68
222
3.09
16.44
1.9
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
68
222
3.09
16.44
1.9
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1102
8637
1.35
16.26
1.9
1.7
mg/l
2.0
1.4
3.18
888
6688
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
17
15
11.37
16.20
1.2
2.2
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
109
462
2.39
15.91
1.6
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
39
89
4.41
15.87
1.8
1.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
39
90
4.36
15.65
1.3
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3551
38218
0.77
15.60
4.7
4.9
mmol/l
6.0
6.0
0.39
3161
34287
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
40
95
4.24
15.48
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
497
3410
1.51
15.44
4.0
4.2
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
17
17
10.03
14.91
1.7
1.6
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
16
15
10.70
14.64
1.1
1.1
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
3100
28100
1.26
14.02
5.0
4.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1101
13554
0.76
13.89
3.0
3.2
mmol/l
7.3
7.4
0.61
877
11260
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
35
82
4.29
13.81
1.7
1.4
%
10.5
5.4
0.59
22
36
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1363
11226
1.29
13.76
2.1
2.3
mg/l
3.5
3.0
7.82
1167
9533
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
198
1110
1.82
13.69
1.5
1.6
iu/ml
0.4
8.9
0.89
51
243
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
19
25
7.62
13.55
1.0
1.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
1060
13082
0.76
13.55
3.2
3.3
mg/l
650.2
336.7
1.12
686
8409
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
25
45
5.58
13.34
1.8
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
25
45
5.58
13.34
1.8
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
25
45
5.58
13.34
1.7
1.2
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
28
56
5.02
13.34
1.9
3.6
ng/l
98.0
103.5
0.08
17
26
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
157
825
1.93
13.29
1.7
1.3
mmol/l
3.8
3.8
0.20
145
764
(3020682) Albumin/Creatinine [Ratio] in Urine
1131
13800
0.77
13.18
3.9
4.0
mg/mmol
8.7
9.8
0.44
737
8822
(3014576) Chloride [Moles/volume] in Serum or Plasma
751
5715
1.37
13.12
7.6
6.7
mmol/l
103.9
104.4
1.99
730
5580
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
528
3799
1.43
12.81
2.7
2.4
u/l
33.5
50.5
0.74
456
3243
(1761868) Lipid panel - Serum or Plasma
971
12043
0.76
12.72
2.9
3.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
79
321
2.48
12.72
1.1
1.1
—
—
—
0
0
(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid
26
51
5.12
12.67
1.2
1.3
u/l
23.2
17.9
0.42
21
33
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
186
1055
1.79
12.40
2.8
2.4
%
225.5
198.3
3.48
179
1000
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
34
85
4.02
12.35
1.2
1.3
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
14
14
10.02
12.23
1.5
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1550
13141
1.26
12.03
3.2
3.4
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
32
79
4.07
11.83
1.3
1.2
mmol/l
3.4
2.0
0.45
22
55
(3014111) Lactate [Moles/volume] in Serum or Plasma
545
4000
1.41
11.80
5.4
6.7
mmol/l
1.6
1.4
2.59
529
3831
(3035933) Granulocytes/100 leukocytes in Blood
33
84
3.95
11.71
3.2
1.7
—
—
—
0
0
(3013512) EKG study
1496
12664
1.26
11.69
4.8
4.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
876
6934
1.32
11.65
3.2
3.1
e6/l
2.1
2.1
0.06
522
3866
(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method
11
0
+∞
11.46
1.0
0.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
438
3130
1.44
11.00
5.1
4.5
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
642
4907
1.35
10.80
1.9
1.8
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
78
344
2.29
10.54
1.2
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
85
390
2.20
10.45
1.1
1.1
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
79
353
2.26
10.36
1.5
1.4
g/l
0.4
0.4
0.12
55
250
(3028192) IgG subclass 2 [Mass/volume] in Serum
79
353
2.26
10.36
1.5
1.4
g/l
2.6
3.0
0.58
55
249
(3027135) IgG subclass 1 [Mass/volume] in Serum
79
353
2.26
10.36
1.5
1.4
g/l
6.3
7.0
0.60
55
248
(3016018) Differential panel - Cerebral spinal fluid
83
380
2.20
10.27
1.8
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
112
575
1.97
10.24
2.0
2.6
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
13
15
8.69
10.23
1.9
1.7
—
—
—
0
0
(4062490)
79
356
2.24
10.16
1.5
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
63
258
2.46
10.06
2.2
1.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
167
983
1.72
9.87
2.7
2.5
%
15.5
16.0
0.63
64
512
(3041918) Cholesterol [Moles/volume] in Pleural fluid
33
96
3.45
9.72
1.1
1.2
mmol/l
1.5
1.7
0.45
25
64
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
117
621
1.90
9.72
1.7
2.1
u/l
2425.6
4208.8
0.58
40
252
(3023410) Appearance of Cerebral spinal fluid
76
346
2.21
9.56
2.1
1.5
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
46
166
2.79
9.46
37.2
27.6
ug/l
113.0
112.1
0.03
38
140
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
14
20
7.02
9.28
2.4
6.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
341
2403
1.45
9.24
2.8
2.9
e6/l
0.4
0.3
1.06
336
2357
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
27
71
3.82
9.21
1.7
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
31
90
3.46
9.17
1.7
1.3
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
23
54
4.27
9.11
1.1
1.5
%
82.7
75.4
0.57
18
47
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
118
643
1.85
9.07
1.3
1.2
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
11
12
9.18
8.98
1.7
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2679
24496
1.20
8.96
3.9
3.2
u/l
86.0
53.0
17.62
2491
22447
(3006922) Hepatitis E virus Ab [Presence] in Serum
55
224
2.47
8.93
1.1
1.1
—
—
—
0
0
(4281824)
77
363
2.14
8.91
1.2
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
35
112
3.14
8.90
1.5
1.1
—
—
—
0
0
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
12
15
8.02
8.86
1.7
1.3
mg/l
0.9
3.3
—
6
7
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
12
15
8.02
8.86
1.7
1.3
mg/l
0.5
3.9
—
5
9
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
12
15
8.02
8.86
1.7
1.3
mg/l
0.2
1.2
—
5
10
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
12
15
8.02
8.86
1.7
1.3
mg/l
0.5
1.4
—
7
7
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
12
15
8.02
8.86
1.7
1.3
mg/l
0.9
2.0
—
6
8
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
19
39
4.89
8.82
1.0
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1038
8667
1.25
8.77
4.3
4.0
ng/l
380.9
524.9
0.31
869
7233
(3032057) Clostridioides difficile [Presence] in Stool
34
108
3.16
8.75
1.9
2.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
107
572
1.89
8.74
1.4
1.6
g/l
0.7
0.9
0.73
78
440
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
76
361
2.12
8.64
1.4
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4132
39431
1.25
8.62
33.1
16.1
mg/l
31.0
25.9
15.91
3838
31826
(3024471) HLA-A [Type]
35
115
3.06
8.53
1.0
1.0
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
83
410
2.04
8.52
1.2
1.2
u/l
60.5
57.1
0.12
55
268
(40758358) Immune stain study
12
16
7.52
8.41
1.0
1.0
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
398
2939
1.38
8.29
7.3
6.5
mmol/l
24.8
24.5
1.07
369
2737
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1182
13754
0.82
8.23
4.0
4.5
%
22.0
22.0
0.01
595
7073
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
48
191
2.53
8.21
1.0
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
13
9
14.47
8.19
1.2
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
26
73
3.57
8.11
1.7
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
692
5554
1.28
8.11
1.2
1.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
668
5343
1.29
8.04
6.5
6.9
mmol/l
1.5
1.0
2.15
513
4125
(3052851) Hemolysis interference index of Serum or Plasma
203
1330
1.55
7.89
3.5
3.5
—
—
—
0
0
(3036489) Thrombin time
218
1451
1.52
7.88
2.5
2.0
s
21.9
21.6
0.22
207
1301
(3023487) Leukocytes [#/volume] in Peritoneal fluid
41
154
2.68
7.88
1.3
2.3
e6/l
2202.2
5485.4
0.30
33
116
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
50
209
2.41
7.73
1.1
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
50
209
2.41
7.73
1.1
1.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
109
611
1.80
7.71
1.2
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
886
7385
1.24
7.50
3.1
2.9
e6/l
1.2
1.1
0.12
532
4286
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
23
63
3.66
7.45
1.6
1.3
ng/l
112.9
94.5
0.14
18
43
(3003338) MCHC [Mass/volume]
3016
32167
0.85
7.41
39.1
20.8
g/l
330.8
332.0
11.70
2987
31831
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
37
137
2.71
7.33
1.3
2.1
e6/l
14266.9
18564.4
0.12
25
80
(3027801) Oxygen [Partial pressure] in Arterial blood
662
5358
1.27
7.22
6.4
6.8
kpa
11.8
12.0
0.65
624
5083
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
662
5359
1.27
7.21
6.5
6.9
kpa
5.0
5.1
0.80
620
5082
(3027273) Bicarbonate [Moles/volume] in Venous blood
310
2258
1.40
7.04
3.5
3.5
mmol/l
25.0
25.2
0.37
304
2184
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
77
400
1.94
6.94
1.1
1.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
458
3558
1.32
6.85
4.0
3.2
kpa
4.7
4.6
0.42
442
3419
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
159
2420
0.65
6.83
1.6
1.8
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
283
2049
1.40
6.67
2.9
3.2
pmol/l
4.3
4.4
2.45
249
1784
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3385
35644
0.85
6.59
5.0
4.7
mu/l
3.0
2.1
0.52
3070
32052
(3020891) Body temperature
258
1844
1.42
6.55
4.9
4.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
55
259
2.14
6.49
3.4
3.7
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
162
1059
1.55
6.43
1.4
1.5
g/l
0.2
0.2
0.53
151
1000
(40757373) Influenza virus identified in Isolate
29
102
2.85
6.35
1.4
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
165
1091
1.53
6.23
1.5
1.5
g/l
1.2
1.2
0.18
157
1028
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
458
5759
0.78
6.22
1.2
1.2
u/ml
14.2
13.8
0.03
140
2111
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
523
4188
1.28
6.21
3.3
3.0
ng/l
280.4
235.2
1.07
487
3825
(3011544) Albumin [Mass/volume] in Pleural fluid
19
52
3.66
6.19
1.1
1.2
g/l
19.5
17.0
0.55
19
43
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
835
9812
0.82
6.14
2.7
3.2
ug/l
0.8
0.8
0.52
575
6840
(3016502) Oxygen saturation in Arterial blood
591
4813
1.26
6.10
6.9
7.2
%
95.0
95.4
0.67
565
4623
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
165
1101
1.52
5.99
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
166
1112
1.51
5.92
1.3
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
149
977
1.54
5.87
1.3
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
34
136
2.51
5.85
1.4
2.0
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
365
2810
1.32
5.84
1.9
1.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
166
1119
1.50
5.75
1.3
1.2
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
16
41
3.91
5.71
1.1
1.0
iu/ml
44.0
15.0
—
6
15
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
47
220
2.15
5.68
1.6
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1547
17150
0.86
5.66
4.7
5.2
ug/l
5.5
3.8
1.70
1370
15249
(3027974) Hepatitis B virus e Ag [Presence] in Serum
10
17
5.89
5.62
2.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
97
1575
0.61
5.60
1.3
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
277
2063
1.36
5.55
1.5
1.3
u/ml
248.1
224.5
0.11
236
1893
(3048879) Bone marrow aspiration report
34
140
2.44
5.52
2.0
1.8
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
47
223
2.12
5.50
1.6
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
159
1075
1.49
5.45
2.9
3.3
kpa
7.9
8.0
0.09
143
994
(3020393) Adenovirus Ag [Presence] in Stool
15
38
3.96
5.43
1.1
1.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
213
1525
1.41
5.41
3.1
3.1
g/l
0.4
0.3
0.18
117
640
(3029937) Albumin [Presence] in Urine by Test strip
1221
10785
1.17
5.41
4.4
4.2
estimate
0.0
0.0
0.31
460
3517
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
104
643
1.63
5.29
1.2
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
99
605
1.65
5.27
3.1
2.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1955
21229
0.87
5.22
2.9
2.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
4191
43167
0.84
5.22
45.2
23.7
g/l
125.6
134.4
203.18
4134
42366
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
23
80
2.88
5.18
1.0
1.1
pmol/l
1.4
7.6
—
5
9
(40765089) Chromosome analysis panel - Blood by G-banded
17
49
3.48
5.16
1.0
1.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
4192
43169
0.84
5.16
45.0
23.6
e9/l
7.1
6.9
2.81
4103
41688
(3026361) Erythrocytes [#/volume] in Blood
4191
43157
0.84
5.14
45.0
23.5
e12/l
4.2
4.5
154.93
4097
41683
(3035941) MCH [Entitic mass]
4191
43155
0.84
5.13
44.7
23.4
pg
30.3
30.4
3.95
4129
42347
(3024731) MCV [Entitic volume]
4191
43155
0.84
5.13
44.8
23.5
fl
91.5
91.4
0.72
4128
42346
(4015189)
31
127
2.45
5.11
1.9
2.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
43
204
2.12
5.06
1.1
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
4191
43142
0.84
5.03
45.0
23.5
e9/l
239.4
243.4
2.51
4106
41831
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
41
192
2.14
4.99
1.0
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
44
213
2.07
4.92
1.2
1.1
u/l
57.5
29.6
1.23
34
158
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
44
213
2.07
4.92
1.2
1.1
u/l
134.1
85.8
1.50
35
161
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
44
213
2.07
4.92
6.1
6.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
39
180
2.18
4.92
1.3
1.3
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
224
1646
1.38
4.92
4.0
3.7
mmol/l
1.5
1.4
0.19
214
1615
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
22
78
2.83
4.81
1.5
1.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1167
10372
1.16
4.70
3.9
3.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
173
1227
1.42
4.69
3.2
3.5
mmol/l
24.7
24.9
0.20
147
1066
(1002224) Polysomnography panel
74
1218
0.60
4.58
1.1
1.1
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
11
25
4.41
4.56
1.1
1.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
147
1022
1.45
4.45
1.2
1.2
titre
101.0
96.6
0.09
20
76
(3024869) Neuronal Ab [Presence] in Serum
21
76
2.77
4.44
1.1
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
214
1590
1.36
4.42
1.4
1.3
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
66
1106
0.59
4.41
1.3
1.7
mg/l
4.0
3.9
0.05
52
781
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1654
18014
0.88
4.39
2.0
2.1
pmol/l
90.3
93.6
2.14
930
9455
(21494755) Public health laboratory ask at order entry panel
163
2254
0.71
4.32
1.3
1.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
276
2140
1.31
4.27
3.2
2.7
%
1.3
1.2
0.48
270
2127
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
57
318
1.80
4.27
1.1
1.1
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
270
2089
1.31
4.25
2.9
2.7
%
0.7
0.7
0.93
261
1997
(3047181) Lactate [Moles/volume] in Blood
194
1430
1.37
4.23
6.9
5.9
mmol/l
1.5
1.3
0.95
163
1264
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
48
255
1.89
4.20
1.6
1.6
u/l
5.1
6.6
0.35
24
115
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
14
41
3.42
4.18
1.0
1.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1780
16407
1.13
4.11
2.9
2.9
ug/l
363.2
146.7
21.05
1637
14965
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
16
52
3.08
4.08
1.1
1.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
8
10
8.01
4.06
1.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
20
75
2.67
3.98
1.6
1.6
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
67
401
1.68
3.96
1.3
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
188
1398
1.36
3.91
4.2
3.9
mmol/l
3.9
3.9
0.07
169
1299
(3008295) Osmolality of Serum or Plasma
72
442
1.64
3.87
1.2
1.4
mosm/kgh2o
279.2
277.5
0.29
60
330
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
240
0.29
3.85
1.3
1.5
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
61
359
1.71
3.84
1.1
1.1
—
21.1
—
0
5
(3021901) Oxygen saturation in Capillary blood
128
894
1.44
3.84
2.8
3.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
743
6474
1.17
3.82
23.1
28.3
inr
1.4
1.4
0.43
115
906
(3026389) Candida sp identified in Specimen by Organism specific culture
80
506
1.59
3.82
1.3
1.4
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
9
15
6.01
3.81
2.2
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
518
6097
0.83
3.79
1.2
1.3
iu/ml
45.7
36.8
0.52
159
1866
(3003181) Sodium [Moles/volume] in Urine
116
798
1.46
3.77
1.3
1.3
mmol/l
61.9
62.7
0.07
96
642
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
6
5
12.01
3.76
1.0
1.0
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
53
302
1.76
3.75
5.3
5.0
u/ml
63.2
48.3
0.16
19
85
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
89
581
1.54
3.72
2.0
2.1
mg/l
37.2
23.6
1.24
26
141
(3044007) Cell count panel - Peritoneal fluid
28
128
2.19
3.69
1.4
2.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
66
402
1.65
3.68
1.3
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
24
103
2.34
3.66
1.5
2.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
235
1827
1.30
3.62
1.2
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
515
4371
1.20
3.60
7.5
7.7
g/l
114.4
120.7
9.56
494
4210
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
36
184
1.96
3.57
1.5
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
308
3796
0.80
3.57
1.7
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1633
15079
1.12
3.55
4.4
4.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
82
533
1.55
3.51
9.1
18.5
mmol/l
7.0
7.5
1.02
69
442
(3014007) Fractional oxyhemoglobin in Arterial blood
353
2898
1.23
3.46
7.6
8.7
%
93.7
93.8
0.08
348
2885
(3006184) Hemoglobin [Mass/volume] in Capillary blood
144
1048
1.38
3.46
2.4
2.2
g/l
121.9
128.1
1.66
96
749
(21494890) Protein electrophoresis panel - 24 hour Urine
79
512
1.55
3.44
1.6
2.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
38
202
1.89
3.38
1.1
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
109
759
1.45
3.37
1.5
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
31
154
2.02
3.34
1.2
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
12
37
3.25
3.34
1.2
1.1
—
—
—
0
0
(21494227) Amikacin free [Mass/volume] in Serum or Plasma
8
14
5.72
3.34
4.9
4.3
mg/l
4.7
3.7
—
8
9
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
119
846
1.42
3.29
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
74
478
1.56
3.28
2.9
3.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
164
1230
1.34
3.28
3.9
4.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
164
1231
1.34
3.27
1.4
1.4
ug/g
259.2
269.4
0.28
103
744
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
6
7
8.58
3.26
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
133
966
1.39
3.26
3.5
3.6
mg/l
31.1
29.2
0.26
91
622
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
121
866
1.41
3.23
1.2
1.3
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
7
11
6.37
3.18
1.0
1.0
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
21
92
2.29
3.09
1.1
1.1
%
74.6
85.0
0.46
11
51
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
21
93
2.26
3.02
1.1
1.3
%
72.5
83.5
0.39
11
53
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
107
761
1.41
2.99
1.2
1.3
u/l
121.5
40.7
1.40
92
659
(3016135) IgD [Mass/volume] in Serum
5
5
10.01
2.98
1.2
1.0
mg/l
11.7
44.6
—
5
5
(3051611) Lipemic interference index of Serum or Plasma
70
458
1.54
2.97
3.2
3.5
—
—
—
0
0
(3004451) EKG impression Narrative
41
234
1.76
2.95
1.1
1.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
28
141
1.99
2.94
1.4
1.2
g/l
1.2
0.2
—
5
10
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
347
2897
1.21
2.93
7.6
8.6
%
0.7
0.7
0.73
341
2871
(3011325) HIV 1+2 Ab [Presence] in Serum
7
13
5.39
2.87
1.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
6
9
6.67
2.86
1.0
1.0
—
—
—
0
0
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
6
9
6.67
2.86
1.2
1.0
u/field
1.0
0.9
—
6
9
(3039443) Prostate specific Ag panel - Serum or Plasma
47
756
0.62
2.79
1.7
1.6
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
9
23
3.92
2.77
1.1
1.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
576
5049
1.16
2.76
1.4
1.4
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
66
435
1.52
2.74
1.3
1.2
u/ml
37.4
42.1
—
7
26
(3021960) Folate [Moles/volume] in Serum or Plasma
956
10504
0.89
2.72
1.6
1.6
nmol/l
19.1
20.1
1.38
840
8912
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
484
4192
1.17
2.72
2.2
2.4
ug/l
7.7
7.3
0.11
408
3613
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
19
85
2.24
2.70
1.1
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
129
1706
0.75
2.69
1.0
1.1
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
77
527
1.47
2.67
1.1
1.1
g/l
1.7
1.5
1.85
71
468
(3013139) Helicobacter pylori Ag [Presence] in Stool
205
2541
0.80
2.57
1.2
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
67
979
0.68
2.56
2.0
2.3
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
24
121
1.99
2.55
1.4
1.2
%
13.0
31.8
—
6
14
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
10
33
3.03
2.52
1.1
1.1
—
—
—
0
0
(4010399)
234
2849
0.81
2.50
1.4
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
144
1848
0.77
2.43
1.8
2.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
44
692
0.63
2.42
1.5
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
26
467
0.55
2.40
1.2
1.1
u/ml
2.9
1.8
—
9
185
(40768800) Prostate Pathology biopsy report
80
1117
0.71
2.40
1.1
1.2
—
—
—
0
0
(3016750) Collection duration of Urine
42
258
1.63
2.38
1.9
2.1
min
518.7
487.2
1.58
26
186
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
8
6.25
2.37
4.4
3.8
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
5
8
6.25
2.37
4.4
3.8
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
342
2915
1.19
2.36
7.6
8.5
%
1.4
1.3
0.46
336
2893
(3019309) Folate [Moles/volume] in Red Blood Cells
980
8978
1.11
2.36
1.8
1.8
nmol/l
1230.7
1162.6
1.30
762
6684
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
21
104
2.02
2.35
1.0
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
28
154
1.82
2.33
1.1
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
33
191
1.73
2.33
1.1
1.1
u/l
1.3
1.1
0.36
15
96
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
9
28
3.22
2.30
1.0
1.1
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
6
13
4.62
2.27
1.0
1.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
2067
19648
1.09
2.27
4.1
3.8
estimate
0.0
0.0
0.50
506
3660
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
41
254
1.62
2.26
3.0
3.8
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
24
127
1.89
2.25
3.1
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
23
120
1.92
2.25
4.2
1.9
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
694
7684
0.89
2.24
1.2
1.2
u/ml
1.0
1.8
3.48
152
1941
(3010726) Horse dander IgE Ab [Units/volume] in Serum
19
365
0.52
2.22
1.2
1.1
u/ml
0.1
2.0
—
5
91
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
14
60
2.34
2.21
1.4
1.1
%
64.9
52.8
—
7
23
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
16
325
0.49
2.21
1.4
1.5
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
5
9
5.56
2.21
1.2
1.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
196
1594
1.24
2.21
2.2
2.2
ug/l
390.3
641.7
0.63
176
1508
(40761539) Cells [Type] in Urine sediment by Light microscopy
23
121
1.90
2.20
1.3
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
92
679
1.36
2.16
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
234
1947
1.21
2.13
2.8
2.7
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
39
243
1.61
2.12
1.1
1.1
mg/l
331.6
288.5
0.34
34
202
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
49
2.45
2.10
1.0
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
12
49
2.45
2.10
1.8
1.5
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
111
848
1.32
2.08
1.6
1.6
mu/l
286.3
291.8
0.08
106
778
(3037522) Nuclear Ab [Titer] in Serum
542
4834
1.14
2.07
1.3
1.3
titre
620.2
511.1
0.56
117
1036
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
40
253
1.59
2.06
1.1
1.1
mg/l
51.6
42.4
0.34
34
202
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
385
3358
1.16
2.03
3.3
2.7
ml/min/173m2
61.4
63.0
0.34
150
1406
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
24
132
1.82
2.03
1.0
1.0
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
38
239
1.59
2.01
1.8
1.7
u/field
1.2
3.1
1.50
29
170
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
63
442
1.43
2.00
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
402
0.57
1.98
1.1
1.1
u/ml
0.5
1.7
—
8
168
(3003327) Ova and parasites identified in Stool by Light microscopy
138
1094
1.27
1.97
1.9
1.7
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
27
156
1.73
1.96
23.6
31.9
ug/l
8.1
7.4
0.93
19
140
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
177
2155
0.81
1.95
1.7
1.8
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
5
11
4.55
1.94
2.2
1.2
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
27
157
1.72
1.92
1.1
1.1
ng/l
3454.0
500.4
—
7
40
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
91
685
1.33
1.92
1.3
1.2
u/ml
42.0
39.5
0.05
13
71
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
28
165
1.70
1.90
2.4
2.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
22
121
1.82
1.88
1.3
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
36
554
0.65
1.87
6.2
4.8
umol/l
330.0
349.6
0.42
31
468
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
373
4242
0.87
1.86
1.4
1.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
382
3356
1.15
1.85
3.3
3.8
ng/l
83.7
94.9
1.60
325
2832
(3009261) Glucose [Presence] in Urine by Test strip
2084
19940
1.08
1.83
4.2
3.9
estimate
0.0
0.0
0.24
497
3593
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
21
115
1.83
1.82
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
290
2499
1.17
1.82
9.6
9.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
7
23
3.05
1.80
1.0
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
2057
19686
1.07
1.79
5.5
5.1
estimate
0.0
0.0
0.50
511
3707
(3003888) Timothy IgE Ab [Units/volume] in Serum
25
414
0.60
1.79
1.1
1.1
u/ml
4.8
3.9
0.12
12
200
(3022493) Free Hemoglobin [Mass/volume] in Plasma
29
176
1.65
1.79
1.4
5.3
mg/l
8487.5
67.0
0.48
22
122
(3047007) Chlamydophila sp Ab [Presence] in Serum
60
429
1.40
1.76
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
3392
34756
0.93
1.74
29.7
17.3
%
37.1
39.2
22.56
2143
22930
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
98
760
1.30
1.71
1.3
1.2
u/ml
1.2
6.4
1.11
12
54
(4027681)
30
187
1.61
1.68
1.2
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
128
1030
1.25
1.66
8.5
6.6
mmol/l
11.1
11.3
0.37
111
920
(3018572) Chloride [Moles/volume] in Blood
128
1030
1.25
1.66
8.5
6.7
mmol/l
104.5
105.1
0.63
111
920
(3004775) Volume in Urine collected for unspecified duration
52
367
1.42
1.65
1.9
2.2
ml
796.5
638.7
1.19
29
231
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
92
713
1.30
1.63
2.7
3.3
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
43
2.33
1.60
1.0
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
202
2376
0.84
1.59
1.8
1.9
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
19
107
1.78
1.54
2.2
2.9
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
19
107
1.78
1.54
1.7
1.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
36
240
1.50
1.54
1.3
1.7
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
101
799
1.27
1.54
1.4
1.8
iu/l
5.3
4.5
0.19
21
249
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
17
93
1.83
1.51
1.4
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
68
512
1.33
1.50
1.1
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
408
3661
1.12
1.48
3.6
3.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
83
1060
0.78
1.47
1.7
1.7
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
5
16
3.13
1.44
1.0
2.8
mmol/l
4.4
4.5
—
5
16
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
6
22
2.73
1.43
9.2
6.4
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
12
59
2.04
1.43
1.0
1.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
12
59
2.04
1.43
1.5
1.3
nmol/l
28.3
29.2
0.05
12
48
(3028300) Cannabinoids [Presence] in Urine
62
819
0.75
1.42
1.2
2.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
25
158
1.59
1.37
1.1
1.3
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
9
41
2.20
1.37
1.1
1.1
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
6
23
2.61
1.36
1.3
1.2
ng/l
4906.8
3054.5
—
6
15
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
112
1.70
1.35
1.2
1.1
—
—
—
0
0
(3017704) Immunofixation for Urine
39
273
1.43
1.34
1.2
1.5
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
37
0.00
1.34
0.0
1.8
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
18
105
1.72
1.33
2.6
2.1
mmol/l
6.5
7.9
—
9
64
(3000764) Benzodiazepines [Presence] in Urine
62
809
0.76
1.32
1.2
2.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
18
106
1.70
1.29
1.0
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
18
106
1.70
1.29
1.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
48
646
0.74
1.28
1.3
1.3
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
119
983
1.22
1.28
1.3
1.2
u/ml
49.1
35.3
0.28
14
56
(3045716) Anion gap in Serum or Plasma
13
231
0.56
1.28
1.2
2.1
mmol/l
10.4
9.4
—
7
183
(3027008) Opiates [Presence] in Urine
63
815
0.77
1.27
1.2
2.1
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
11
55
2.00
1.27
1.0
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
245
2781
0.88
1.26
1.2
1.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
62
803
0.77
1.26
1.2
2.1
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
10
191
0.52
1.25
1.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
6
25
2.40
1.24
2.0
2.4
—
—
—
0
0
(4133840)
15
85
1.77
1.22
1.9
1.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
37
2.16
1.21
1.0
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1703
16373
1.06
1.20
2.2
2.2
nmol/l
76.0
78.5
3.05
1558
14402
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
99
1205
0.82
1.20
1.5
1.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
20
312
0.64
1.20
1.1
1.1
u/ml
0.4
3.4
—
9
118
(3016879) Cocaine [Presence] in Urine
59
760
0.77
1.17
1.2
2.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
277
2478
1.12
1.11
7.8
8.9
mmol/l
24.3
24.3
0.11
261
2287
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
19
294
0.64
1.11
2.3
1.7
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
51
1.96
1.11
1.0
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
109
915
1.20
1.04
1.4
1.2
u/ml
2.6
3.4
0.60
17
84
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
22
2.27
1.03
1.2
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
16
98
1.63
1.03
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
32
440
0.73
1.03
1.2
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
34
2.06
1.02
1.1
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
18
114
1.58
1.02
1.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
19
122
1.56
1.02
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
74
909
0.81
1.02
1.4
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
25
171
1.46
1.02
1.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
5
107
0.47
1.00
1.2
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
110
928
1.19
1.00
1.4
1.2
u/ml
6.2
8.0
0.21
22
150
(3000492) Spirometry study
376
3444
1.10
1.00
1.5
1.5
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
27
190
1.42
0.96
1.5
1.6
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
37
491
0.75
0.96
1.2
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
386
4193
0.91
0.96
2.0
2.2
ug/g
191.6
153.1
0.98
315
3273
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
32
233
1.38
0.95
1.1
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3993
40422
0.95
0.94
26.7
15.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
37
277
1.34
0.93
1.1
1.3
mmol/l
11.7
12.0
0.07
15
83
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
128
1106
1.16
0.90
1.8
1.7
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
359
3899
0.91
0.90
1.6
1.8
%
1.6
1.5
0.27
305
3357
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
6
29
2.07
0.89
1.0
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
226
2031
1.12
0.89
1.2
1.2
iu/ml
85.6
136.8
1.72
68
716
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
33
438
0.75
0.87
1.2
1.3
mmol/l
7.7
7.5
0.08
21
317
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
116
1344
0.86
0.87
1.6
1.6
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
6
31
1.94
0.84
1.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
10
57
1.76
0.83
1.9
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
8
139
0.57
0.83
1.4
1.5
—
—
—
0
0
(4212803)
8
46
1.74
0.82
1.1
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
51
633
0.80
0.82
1.2
2.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
32
1.88
0.81
1.0
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
477
4463
1.08
0.81
1.3
1.3
—
—
—
0
0
(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid
0
24
0.00
0.79
0.0
8.2
—
264.8
—
0
18
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
20
282
0.71
0.79
1.1
1.1
u/ml
1.3
4.1
—
9
109
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
33
1.82
0.79
1.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
31
233
1.33
0.79
1.9
1.5
g/l
0.9
0.9
0.31
31
233
(3020491) Glucose [Moles/volume] in Blood
22
304
0.72
0.77
1.3
2.3
mmol/l
7.7
6.8
0.72
17
204
(3017569) Oxygen content in Arterial blood
17
246
0.69
0.77
2.1
2.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
57
694
0.82
0.77
1.7
1.4
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
0
27
0.00
0.77
0.0
2.0
—
1.5
—
0
20
(3036603) Volume of Urine
36
278
1.30
0.77
1.4
1.7
ml
1885.4
1753.0
—
8
71
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
32
416
0.77
0.76
1.7
1.4
%
29.2
27.0
0.11
19
257
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
246
2246
1.10
0.75
1.2
1.3
au/ml
121.2
57.7
—
5
100
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
49
395
1.24
0.75
2.8
2.1
u/field
1.6
1.8
0.12
21
147
(3017446) Testosterone [Moles/volume] in Serum or Plasma
340
3156
1.08
0.73
2.0
2.2
nmol/l
11.2
12.4
1.78
308
2738
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
34
263
1.29
0.73
2.6
1.8
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1361
13175
1.04
0.72
2.2
2.2
u/l
180.6
228.6
1.53
1284
12291
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
20
276
0.72
0.71
1.2
1.4
pmol/l
57.5
166.5
—
9
88
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
9
57
1.58
0.71
1.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
35
273
1.28
0.71
2.8
3.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
5
26
1.92
0.70
1.0
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
15
101
1.49
0.70
1.1
1.1
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
7
119
0.59
0.67
4.1
2.2
nmol/l
135.6
148.7
—
7
106
(4024509)
35
441
0.79
0.67
1.6
1.6
—
—
—
0
0
(4306422)
39
483
0.81
0.65
1.2
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
10
62
1.61
0.65
1.3
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
85
979
0.87
0.64
1.1
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
19
137
1.39
0.64
6.7
2.3
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
19
137
1.39
0.64
6.7
2.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
23
304
0.76
0.64
1.5
1.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
37
297
1.25
0.62
1.9
1.7
—
—
—
0
0
(4094501)
94
1069
0.88
0.61
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
37
298
1.24
0.60
1.2
1.2
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
21
0.00
0.60
0.0
1.0
—
81.1
—
0
13
(3003577) Lead [Moles/volume] in Blood
0
22
0.00
0.59
0.0
1.2
—
0.2
—
0
5
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
36
290
1.24
0.59
1.2
1.2
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
34
272
1.25
0.59
1.3
1.9
umol/l
4.1
10.6
1.80
22
181
(3032773) Endomysium IgG Ab [Titer] in Serum
21
277
0.76
0.59
1.1
1.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
124
1113
1.12
0.57
2.2
2.3
ug/min
122.3
105.6
0.17
62
663
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
101
1137
0.89
0.57
1.6
1.9
—
—
—
0
0
(3019977) pH of Arterial blood
33
265
1.25
0.56
4.7
2.5
ph
7.4
7.4
0.08
11
95
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
8
55
1.46
0.56
1.0
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
94
1061
0.88
0.56
1.9
1.6
e6/l
9816.7
14123.3
1.12
71
763
(3024263) Appearance of Synovial fluid
19
251
0.76
0.55
1.7
1.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
45
536
0.84
0.54
1.8
1.5
%
66.7
61.0
0.60
30
339
(3029075) Extractable nuclear Ab panel - Serum
14
99
1.42
0.54
1.1
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
30
372
0.81
0.53
1.2
2.8
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
17
125
1.36
0.53
1.1
1.1
miu/ml
978.5
1662.7
1.93
17
125
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
210
1946
1.08
0.52
6.1
4.9
%
1.6
1.6
0.26
190
1821
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2881
29190
0.97
0.50
4.2
3.9
pmol/l
15.0
15.0
0.73
2608
26101
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
15
202
0.74
0.50
1.0
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
20
153
1.31
0.50
1.5
2.2
umol/l
78.1
145.2
—
10
89
(40757494) Bilirubin.total [Moles/volume] in Blood
30
243
1.24
0.49
2.4
2.2
umol/l
14.9
22.8
—
6
24
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
12
84
1.43
0.49
2.1
1.7
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
7
45
1.56
0.49
17.7
9.6
—
—
—
0
0
(44806420)
19
145
1.31
0.48
2.4
2.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
20
256
0.78
0.47
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
32
263
1.22
0.47
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
32
263
1.22
0.47
1.2
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
32
263
1.22
0.47
1.2
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
48
1.46
0.46
1.0
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
29
236
1.23
0.46
1.0
1.1
nmol/l
4.3
7.2
—
6
53
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
23
182
1.26
0.46
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
964
9368
1.04
0.44
1.6
1.7
pmol/l
439.3
24595302.5
5.60
788
7652
(3034426) Prothrombin time (PT)
15
112
1.34
0.44
1.3
1.3
—
—
—
0
0
(4146454)
45
524
0.86
0.44
2.9
2.7
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
32
266
1.20
0.43
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
32
266
1.20
0.43
1.2
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
32
266
1.20
0.43
1.2
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
30
361
0.83
0.43
1.1
1.6
u/ml
25.8
25.8
—
5
82
(3002385) Erythrocyte distribution width [Ratio]
3213
31800
1.03
0.43
36.4
19.5
%
14.5
13.8
84.36
3175
31021
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
8
57
1.40
0.42
2.3
2.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
44
510
0.86
0.42
1.3
1.2
u/ml
1.8
4.7
3.79
16
226
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
15
0.00
0.41
0.0
9.5
—
—
—
0
0
(37019676) Renin [Units/volume] in Plasma --supine
0
16
0.00
0.41
0.0
1.1
—
10.3
—
0
10
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
17
0.00
0.40
0.0
1.2
—
3.2
—
0
17
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
49
560
0.87
0.39
1.6
1.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
69
771
0.89
0.39
1.8
1.5
—
—
—
0
0
(4034850)
120
1303
0.92
0.39
14.7
11.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
10
71
1.41
0.39
1.2
1.1
—
—
—
0
0
(4198724)
7
106
0.66
0.39
1.1
1.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
221
2342
0.94
0.38
2.4
2.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
73
810
0.90
0.37
1.8
1.8
nmol/l
1.0
0.8
1.04
56
672
(3023511) Choriogonadotropin [Units/volume] in Urine
25
300
0.83
0.36
1.4
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
923
9460
0.97
0.36
4.0
3.8
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
6
44
1.36
0.34
3.8
4.3
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
145
1355
1.07
0.34
1.2
1.2
u/ml
4.9
1.3
—
10
122
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
13
100
1.30
0.33
1.2
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
11
144
0.76
0.33
1.2
2.2
ug/l
289.0
74.5
0.34
11
131
(3051101) Glucose [Moles/volume] in Cord blood
6
86
0.70
0.33
11.7
6.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
203
1923
1.06
0.32
6.6
5.0
%
0.9
0.9
0.35
185
1803
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
13
101
1.29
0.31
1.0
1.8
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
14
110
1.27
0.31
1.1
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
30
348
0.86
0.31
2.7
2.4
%
10.7
10.8
0.03
30
348
(44813793)
18
219
0.82
0.31
1.1
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
7
96
0.73
0.30
1.0
1.6
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
14
175
0.80
0.30
2.4
2.2
umol/l
58.6
54.4
0.13
14
140
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
55
495
1.11
0.30
1.3
1.3
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
97
1046
0.93
0.30
1.6
1.8
nmol/l
45.0
42.6
0.48
97
1002
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
14
111
1.26
0.30
1.3
2.2
%
208.9
189.4
0.27
14
101
(3008116) Ketones [Moles/volume] in Urine by Test strip
12
93
1.29
0.30
1.1
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3659
36820
0.98
0.29
29.4
15.3
ml/min/173m2
78.6
76.3
8.43
3299
30456
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
56
1.25
0.29
8.4
6.9
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
7
56
1.25
0.29
2.4
2.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
54
598
0.90
0.29
1.1
1.1
iu/ml
1.4
1090.1
—
10
121
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
110
0.73
0.28
1.9
1.5
ug/l
11.5
9.2
—
8
110
(3022689) Creatine [Moles/volume] in Urine
8
110
0.73
0.28
1.4
1.5
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
8
111
0.72
0.28
4.3
4.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
27
232
1.16
0.28
2.5
2.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
14
112
1.25
0.28
1.2
1.5
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
33
289
1.14
0.28
1.2
1.1
mmol/l
31.1
35.1
0.85
33
243
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
47
522
0.90
0.27
1.3
1.2
u/ml
3.1
3.5
—
10
178
(3005033) Fetal Nuchal fold Thickness US
34
299
1.14
0.27
1.3
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
510
5244
0.97
0.27
3.9
4.7
%
32.0
32.9
0.95
347
3451
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4141
41595
0.98
0.27
21.0
10.8
u/l
27.9
26.1
4.14
4046
39826
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
15
122
1.23
0.27
2.6
2.1
ug/l
1.3
1.2
0.04
15
111
(1617658) Protocol used for examination of sentinel lymph nodes
30
262
1.15
0.26
1.0
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
32
362
0.88
0.25
1.2
1.2
%
86.1
94.3
0.97
32
340
(3000034) Microalbumin [Mass/volume] in Urine
36
404
0.89
0.25
2.9
3.0
mg/l
23.5
35.1
0.56
30
313
(3047352) Trisomy 18 risk [Likelihood] in Fetus
34
301
1.13
0.25
1.3
1.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
15
123
1.22
0.25
2.3
2.0
mmol/l
1.3
0.7
0.29
15
114
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
13
105
1.24
0.24
1.0
1.9
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
39
434
0.90
0.24
1.6
1.3
e6/l
8329.2
132799.7
3.15
27
300
(3045424) Erythrocytes [Presence] in Urine
64
693
0.92
0.23
1.7
1.5
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
5
38
1.32
0.23
1.4
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
21
243
0.86
0.23
1.1
1.4
u/ml
1.1
1.3
—
7
124
(3006653) Thiamine [Moles/volume] in Blood
17
200
0.85
0.22
1.3
1.2
nmol/l
135.7
139.3
0.09
17
200
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
10
79
1.27
0.22
1.6
3.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
42
1.19
0.21
1.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
11
0.00
0.21
0.0
1.4
—
2.0
—
0
11
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
5
43
1.16
0.21
2.2
2.8
—
—
—
0
0
(3007542) Rye IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.1
—
0
5
(43055459) Dabigatran [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.1
—
261.8
—
0
6
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
14
0.00
0.20
0.0
5.9
—
389.2
—
0
14
(3044889) 12 lead EKG panel
2818
28363
0.99
0.20
4.7
4.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
112
0.80
0.20
7.3
7.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
20
229
0.87
0.20
1.2
1.5
u/l
17.2
6.4
0.62
15
195
(3022621) pH of Urine by Test strip
287
2785
1.03
0.19
3.4
3.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
6
52
1.15
0.19
3.5
2.5
u/field
0.7
0.6
—
6
52
(3043238) Trisomy 21 risk [Likelihood] in Fetus
34
308
1.10
0.19
1.4
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
10
81
1.24
0.18
1.3
1.2
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
4125
41115
1.02
0.18
32.5
19.0
mmol/l
138.9
139.6
45.11
4047
39982
(3041806) Other cells [#/volume] in Blood by Manual count
7
62
1.13
0.17
1.3
1.8
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
27
243
1.11
0.17
2.0
2.1
ug/min
271.3
203.8
—
6
63
(3000285) Sodium [Moles/volume] in Blood
5
67
0.75
0.17
1.4
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
23
205
1.12
0.17
2.2
4.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
11
92
1.20
0.16
1.0
1.2
umol/24h
0.4
0.7
—
5
48
(3035320) C reactive protein [Mass/volume] in Body fluid
32
293
1.09
0.15
1.9
2.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
51
478
1.07
0.15
1.2
1.3
nmol/l
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
100
958
1.04
0.14
3.2
2.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
87
831
1.05
0.14
1.6
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
227
2329
0.97
0.14
1.4
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
22
243
0.90
0.13
12.6
13.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
97
0.82
0.13
7.5
7.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
67
703
0.95
0.12
1.4
1.5
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
49
519
0.94
0.12
1.5
1.4
mu/l
76.9
63.5
0.10
42
460
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
546
5384
1.02
0.12
11.9
7.8
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
138
1421
0.97
0.11
1.1
1.1
u/ml
—
1.2
—
0
22
(3020191) Ethanol [Moles/volume] in Serum or Plasma
32
298
1.07
0.11
1.3
1.3
promille
0.8
1.1
0.74
20
229
(4268621)
37
347
1.07
0.11
2.2
2.3
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
28
301
0.93
0.10
1.0
1.0
ng/l
992.6
683.9
2.50
19
194
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
18
163
1.10
0.10
2.4
2.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
883
8750
1.01
0.10
4.5
4.3
kg/l
1.0
1.0
0.30
160
1317
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
28
300
0.93
0.10
1.0
1.0
ng/l
40.1
45.6
0.35
20
196
(3035611) Eosinophils/100 leukocytes in Synovial fluid
5
45
1.11
0.09
1.6
1.4
%
0.6
0.9
—
5
30
(3027456) Digoxin [Moles/volume] in Serum or Plasma
105
1082
0.97
0.09
2.6
3.1
nmol/l
0.9
0.8
0.16
69
815
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
46
1.09
0.09
1.2
1.4
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
48
1.04
0.09
1.0
1.1
umol/24h
1.5
1.8
—
5
48
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
13
116
1.12
0.09
1.2
1.2
g/l
0.3
0.3
1.48
13
90
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
28
299
0.94
0.09
1.0
1.0
ng/l
328.6
321.6
0.05
20
199
(3025018) Bordetella pertussis Ab [Titer] in Serum
20
184
1.09
0.09
1.3
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
126
1228
1.03
0.09
1.7
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
234
2300
1.02
0.08
3.9
3.6
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
5
61
0.82
0.08
6.6
12.7
mmol/l
4.9
5.8
—
5
61
(3010370) Gastrin [Moles/volume] in Serum or Plasma
5
62
0.81
0.08
1.4
2.0
pmol/l
18.1
40.8
—
5
50
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
24
256
0.94
0.07
1.5
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
8
77
1.04
0.07
7.6
7.3
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
38
397
0.96
0.06
1.2
1.2
nmol/l
377.6
334.0
0.70
33
321
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
101
0.89
0.06
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
101
0.89
0.06
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
101
0.89
0.06
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
101
0.89
0.06
1.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
43
414
1.04
0.06
1.0
1.1
u/ml
1.9
2.5
0.47
13
151
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
19
178
1.07
0.05
1.3
1.1
ratio
1.2
1.1
—
10
55
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
47
486
0.97
0.05
1.3
1.3
pmol/l
330.8
274.0
0.41
37
372
(3036670) Protein [Mass/volume] in Synovial fluid
16
149
1.07
0.05
1.3
1.2
g/l
36.6
40.2
—
10
75
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
38
366
1.04
0.05
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
38
366
1.04
0.05
1.3
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
41
396
1.04
0.05
1.4
1.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
4124
41197
1.01
0.05
32.9
19.2
mmol/l
4.0
4.0
0.72
4044
39998
(3011288) Drugs identified in Urine by Screen method
52
535
0.97
0.05
1.4
3.1
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
28
268
1.05
0.04
1.6
1.9
nmol/l
19.5
17.9
0.42
28
250
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
14
130
1.08
0.04
1.1
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
38
367
1.04
0.04
1.3
1.4
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
41
397
1.03
0.04
1.3
1.3
nmol/l
1.2
1.5
1.33
34
354
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
38
368
1.03
0.04
1.3
1.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
10
109
0.92
0.04
1.1
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
15
141
1.06
0.03
1.1
1.2
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
21
219
0.96
0.03
1.6
1.3
nmol/l
1.2
1.2
0.05
14
168
(4211845)
23
221
1.04
0.03
2.2
3.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
15
157
0.96
0.01
1.2
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
90
908
0.99
0.01
1.0
1.1
u/ml
3.6
7.6
—
10
85
(3013166) Neutrophils/100 leukocytes in Synovial fluid
15
156
0.96
0.00
1.4
1.3
%
54.0
60.0
0.26
15
129
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
102
0.98
0.00
1.3
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
18
182
0.99
0.00
1.0
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
49
488
1.00
0.00
1.0
1.1
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
15
146
1.03
0.00
1.5
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
46
463
0.99
0.00
1.5
1.2
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
11
111
0.99
0.00
1.4
1.2
%
112.6
110.2
0.15
11
94
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
15
149
1.01
0.00
1.3
1.8
ug/l
45.2
57.6
0.50
15
144
(3044242) Glucose [Moles/volume] in Arterial blood
26
259
1.00
0.00
1.5
2.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
53
529
1.00
0.00
1.2
1.3
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
9
0.00
0.00
0.0
6.1
—
67.4
—
0
9
(3007463) Buprenorphine [Presence] in Urine
0
9
0.00
0.00
0.0
5.7
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3036180) Methadone [Presence] in Urine
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
5
49
1.02
0.00
1.6
1.4
—
—
—
0
0
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.1
—
33.1
—
0
7
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
1.4
—
0
7
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
7
0.00
0.00
0.0
1.4
—
3554.3
—
0
7
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
28.6
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
27.0
—
0
6
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
7
76
0.92
0.00
1.7
1.5
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
7
71
0.99
0.00
1.3
1.5
ng/l
116.3
142.9
—
7
71
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.8
—
0.3
—
0
5
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
53
0.94
0.00
1.2
1.4
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
5
51
0.98
0.00
1.6
2.7
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
60
1.00
0.00
1.0
1.1
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_UNCERTAIN_SECONDARY – Secondary uncertain malignant neoplasm
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).